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1. Introduction 
 
 
Characteristics of living organisms are result of gradually evolutive adaptation toward 
ambient, also humans are exposed to environmental conditions and then during history 
course they have developed defence mechanisms adapting to habitat. 
One of the most variable phenotypes in human is pigmentation; the colour of skin and also 
of hair and eyes is primarily determined by melanin, a complex group of biopolymers 
synthesized by specialized cells called melanocytes. Stimulation of melanin synthesis is the 
main defence against the damaging effects of ultraviolet radiation and skin colour is the 
principal outcome of adaptation toward UV rays. Melanin acts as an optical and chemical 
photoprotective filter reducing the penetration of radiation into subepidermal tissues. Skin 
coloration is strongly correlated with absolute latitude and then with UV radiation levels to 
which humans are exposed, closer are persons to the equator greater is UV energy that 
reachs the earth surface and consequently natural selection have favoured in tropical 
regions dark pigmentation, because highly melanised epidermis affords better protection 
against UV-induced injuries such as sunburn, skin cancer and sweat glands damages. 
Lighter skin instead can be explained as adaptation to the lower UV radiation incidence in 
regions far from the equator and the importance of maintaining UV-induced biosynthesis 
of vitamin D3, since increasing the melanin in human skin increases the time of exposure 
to UV light that is needed to maximize synthesis of previtamin D3. Sunlight is not only 
dangerous for skin, but also degrade some essential nutrients such as folate, a fundamental 
molecule for nucleotide and, therefore, DNA biosynthesis. Folate deficiency can result in 
complications during pregnancy and multiple fetal abnormalities, including neural tube 
defects, such as spina bifida and anencephalus and it was significant cause of perinatal and 
postnatal mortality in some populations before the introduction of preventive 
supplementation. Deeply melanised skin protects also folate in the blood from photolysis, 
another reason that could have favoured positive selection of people with dark skin in areas 
with high solar intensity together with the lower skin cancer incidence.1,2 
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Dark skin and light skin were adaptations to environments of high ultraviolet light 
exposure and low ultraviolet light exposure, respectively; light skin is most vulnerable to 
UV radiation and fair skinned individuals, living in regions with great incidence of UV 
rays, are at highest risk of developing skin cancer. Although dark skinned persons are less 
affected by UV radiation, they are not completely safe and can also develop, even though 
incidence is lower, UV-induced skin cancers. It is important to remember that exposure to 
UV radiation is dangerous for people all over the world and then to avoid detrimental 
effects of UV radiation it must avoid UV overexposure, particularly during the time of the 
day of higher UV incidence, and protect the skin with sunscreen products when it decide to 
stay in the sun. 
 
 
1.1 Sunlight 
The electromagnetic spectrum of the sun is composed, from shorter wavelengths to higher, 
by: cosmic rays, gamma rays, X ray, UV radiation (UVC, UVB, UVA), visible light, 
infrared rays, microwaves and radio waves (Fig.1). Fortunately higher energy rays, such as 
cosmic rays (below 10-16 m), gamma rays (10-16-10-11 m), X rays (10-11-10-8 m) and UVC 
rays (100-280 nm), are filtered by the stratospheric ozone layer;3 while earth’s surface is 
constantly irradiated by light coming from the sun, composed of 56% infrared waves 
(wavelength, 780-5000 nm), 39% of visible light (400-780 nm), 4,9% of UVA rays (320-
400 nm) and 0,1% of UVB light (290-400 nm).4 Although UVA and UVB rays are a small 
portion of the total radiation reaching the earth, they are responsible for skin, eyes and hair 
damages, because of their higher energy content. The following relationship describes the 
correlation between energy, frequency and wavelength; radiation energy increases 
proportionally with the frequency and decreases with the increase of wavelength.3 
 
E = energy 
v = frequency (Hertz)  
h = Planck’scostant = 6.62 x 10-27  erg/s) 
c = speedof light = 3.0 x 1010 cm/s 
λ = lunghezza d’onda in cm o m 
     1. Introduction 
 3 
 
Figure 1.1 Sunlight 
 
Besides energy, it must be considered also the intensity and the composition of UV 
radiation, since these parameters are not constant but change affected by different factors, 
such as season, ozone layer, transmission, reflexion, altitude, latitude, cloudiness and 
inclination of the sun, which varies during the time of the day. The highest irradiance is at 
higher elevations, because the atmosphere is thinner resulting in an increase of the intensity 
by 4% every 300m of elevation, and at the equator where the sun is most directly so the 
UV radiation travels the least distance through the atmosphere and there is less ozone to 
absorb the UV radiation, since ozone is naturally thinner near the equator. Because UVA 
rays are of longer wavelength compared with UVB, UVA are less affected by altitude or 
atmospheric conditions; on the earth’s surface the ratio of UVA to UVB is 20:1. 
Atmospheric agents as fog, haze, clouds, and pollutants can reduce ultraviolet radiation by 
10–90% while snow, sand, and metal can reflect up to 90%. Sea water can reflect up to 
15% and penetration through water is possible to a depth of 1 m.5,6  
 
 
1.2 The human skin 
The skin is the largest organ of the body, covers the entire body surface and is continuous 
with the mucous membranes. It has several functions involving protection from the 
environment (against external physical, chemical and biological aggressions), tactile 
sensation, immunity defence, regulation of body temperature and secretions. 
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Human skin consists of three layers (fig. 2); a stratified, cellular epidermis and an 
underlying dermis of connective tissue, below the dermis there is the hypodermis, the 
panniculus adiposus, a fatty layer usually designated as ‘subcutaneous’. This is separated 
from the rest of the body by a vestigial layer of striated muscle, the panniculus carnosus.  
The skin shows considerable regional variations, concerning its thickness (varying from 1 
to 4 mm) and distribution of epidermal appendages, so it can be divided in: glabrous skin 
and hair-bearing skin. Hairless skin is found on palms and soles	   and is characterized by 
thick epidermis divided into several well-marked layers, including compact stratum 
corneum, by the presence of encapsulated sense organs within the dermis and by lack of 
hair follicles and sebaceous glands. Hair-bearing skin, on the other hand, has both hair 
follicles and sebaceous glands but lacks of encapsulated sense organs, there is also wide 
differences between the body sites.7,8 
 
Figure 1.2 Human skin. 
 
The epidermis is a stratified squamous epithelium, made of various cell types, the great 
number of which (90-95%) are keratinocytes that undergoing a specific differentiation 
process resulting in the production of flattened, anucleate cells (corneocytes). The 
remaining 5-10% of epidermal cells are mainly melanocytes, which synthesized melanin, 
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Langerhans’ cells, which have immunological functions and Merkel cells, which seem to 
function as mechanoreceptors.  Keratinocytes moves progressively from the basal layer 
towards the skin surface, forming several well-defined layers during its transit, so the 
epidermis can be divided into four distinct layers: stratum basale or stratum germinativum, 
stratum spinosum, stratum granulosum and stratum corneum;  in some body areas (the 
palmoplantar region) an additional layer, the stratum lucidum, can be seen between the 
granular and the horny layers.    
The stratum basal is a continuous layer, generally described as only one cells thick, but 
may be two to three cells thick in glabrous skin and hyperproliferative epidermis. The 
basal cells are small and cuboidal (10–14 nm) and have large nuclei, dense cytoplasm 
containing many ribosomes and dense tonofilament bundles. Immediately above the basal 
cell layer, there is the stratum spinosum; when a basal cell from the basal layer goes up to 
the spinous layer begins to differentiate in a keratinocyte. The stratum spinosum is 
succeeded by the stratum granulosum, here the cells don’t undergo mitotic divisions but 
produce high quantity of keratohyalin and keratin, basal structural proteins of nails and 
hairs. The outermost layer of epidermis is the stratum corneum where cells (now 
corneocytes) have lost nucleus and cytoplasmic organelles. These cells are generally 
already died, flattened, interdigitated and disposed in sheets, they have filamentous keratin 
matrix and a thick cornified envelope within the plasma membrane. 
Epidermal keratinocytes originate from mitotic divisions of stem cells takes 15-30 days to 
go from basal layer towards the skin surface and during migration undergoes 
morphological and biochemical differentiation (keratinisation). The cornified cells 
remaining in the horny layer for about two week, then they are shed from the skin 
surface.7,8 
The dermis is situated under the epidermis, is a connective tissue compressible and elastic, 
highly innervated and vascularized. It consists of supporting matrix or ground substance in 
which polysaccharides and protein are linked to produce macromolecules with a significant 
capacity in retaining water. Within and associated with this matrix are two kinds of 
proteins: elastin and collagen fibers, which have great tensile strength and form the main 
constituent of the dermis. The cells present in the dermis are fibroblasts, mast cells and 
dermal dendrocytes. 
The thickness of the dermis varies considerably with the anatomic location (being much 
thicker on the back, on palms and soles than on the eyelids) and its fine structure varies 
depending on depth, it can be distinguish two layer of dermis: superficial or papillary 
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dermis, reticular or deep dermis. The papillary dermis is made of collagen fibers, arranged 
in loose bundles, and of thin elastic fibers; it forms conic upward projections (dermal 
papillae) that increase the surface of contact between dermis and epidermis allowing a 
better adhesion between these layers; it contains also tactile corpuscles, specialized nerve 
endings acting as mechanoreceptors. The reticular (deep) dermis is made of denser 
collagen bundles and the elastic network is also thicker.7,8 
The hypodermis is a fatty tissue, which plays an important role in thermoregulation, 
insulation, provision of energy (nutritional store) and protection from mechanical injuries. 
It consists of loose connective tissue and is mainly constituted of adipocytes, large, 
rounded cells with a high lipid content in cytoplasm (triglycerides, fatty acids). Adipocytes 
are arranged in primary and secondary lobules, separated by the connective tissue septa 
containing fibroblasts, dendrocytes and mast cells.7,8 
 
1.2.1 Melanocytes and melanogenesis 
Melanocytes are dendritic cells residing in the epidermis, hair follicle and eyes; their 
principal task is to produce the pigment melanin that is responsible for skin hair and eyes 
pigmentation. In the epidermis, melanocytes are approximately 1–2% of epidermal cells; 
they are located in the basal layer in contact with keratinocytes. Within melanocyte the 
pigment melanin is synthesized inside membrane-bound organelles termed melanosomes, 
which at the maturation move to adjacent keratinocytes through dentritic structures. Within 
the keratinoctyes, melanosomes are typically aggregated over the nucleus, to provide 
protection against ultraviolet radiation.9  
Two kinds of melanin are synthesized within melanosome: eumelanin and pheomelanin; 
these biopolymers are both deriving from the L-Tyrosine, which is oxidized by the 
tyrosinase enzyme to dopaquinone, a key intermediate compound of two synthetic 
pathways, the one leading to eumelanin production and the other to pheomelanin 
production. Eumelanogenesis involves transformation of dopaquinone by a series of 
oxidoreduction reactions with production of the intermediates 5,6-dihydroxyindole (DHI) 
and DHI carboxylic acid (DHICA), that undergo polymerization to form eumelanin 
consisting of different oxidative states of 5,6-dihydroxyindole (DHI), 5,6-dihydroxyindole-
2-carboxylic acid (DHICA) units, and pyrrole units derived from their peroxidative 
cleavage. Pheomelanogenesis also starts with dopaquinone, here it is conjugated to 
cysteine to give cysteinyldopa and after further transformation pheomelanin (Fig. 3).10 
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Comparison of the biochemical melanin pathways revealed that eumelanin requires higher 
concentrations of tyrosine together with higher activity and protein levels of the enzymes 
tyrosinase and tyrosinase-related proteins, while pheomelanin synthesis requires 
availability of cysteine and proceeds in the presence of low tyrosine concentrations, low 
activity and level of tyrosinase and absence of tyrosinase-related proteins; from these 
results come out that pheomelanin synthesis is less stringent than those of eumelanin and it 
seems to be the default pathway.11  
Melanin pigments differ for structure, physical and chemical properties; eumelanin is a 
black to brown color pigment, whereas pheomelanin show a yellow to reddish colour, the 
first one is able to scavenge free radical, contrary pheomelanin is photolabile and after 
irradiation generates hydroxyl radicals and superoxide anions, which might contribute to 
UV rays oxidative damages; additionally pheomelanin increases the histamine release that 
contributes to erythema and edema induced after sun exposure. Diverse pigmentary 
phenotypes vary for the amount and the type of melanin synthesized; darkly pigmented 
skin present larger and more pigmented melanosomes enriched in eumelanin than lightly 
pigmented skin, which contains mainly pheomelanins and low concentration of eumelanin, 
furthermore the melanosomes tend to be less pigmented and smaller in size.12  
 
Figure 1.3 Melanin biosynthetic pathways  
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1.3 Effects of UV rays on the organism 
UV rays are the most dangerous radiation reaching the earth surface; the organs mainly 
affected by UV radiation are skin and eyes, since they are directly exposed to sunlight and 
because of the presence in the tissues of chromophores, molecules able to absorb the 
radiation energy, such as melanin, DNA, RNA, proteins, lipids, trans-urocanic acid, and 
aromatic amino acids, as tyrosine and tryptophan.13 
In the past only UVB radiation was believed to be dangerous for tissues, while UVA 
radiation was considered harmless; currently it is known that, although they show different 
properties, also UVA rays are damaging. UVB rays have higher energy content and are 
more cytotoxic and mutagenic than UVA, however UVA rays are able to penetrate deeper 
into the skin reaching the dermis and are responsible for indirect damages by generation of 
reactive oxygen specie. Human exposure to UV radiation causes different acute and 
chronic effects on the skin; acute responses include photodamage, erythema, synthesis of 
vitamin D, tanning and most dangerous immunosuppression and mutation, which are 
responsible of chronic UVR effects such as photocarcinogenesis.14  
The most evident effects following exposure to sunlight are appearance of erythema and 
tanning; the action spectrum for UV-induced tanning and erythema are almost the same, 
however, UVA rays are more efficient in inducing tanning whereas UVB are in inducing 
erythema, because the ability of UV to induce erythema decreases going towards longer 
wavelength, then to produce the same erythemal response its need about 1000 times more 
UVA dose compared with UVB. UVB-induced erythema occurs in about 4 hours after 
exposure, peaks around 8 to 24 hours and fades generally over a day. The erythema is due 
to superficial vasodilatation and is associated with the appearance of apoptotic 
keratinocytes.6  
Tanning is the main auto-protection mechanism of the skin in response to UV radiation 
exposure, devised by evolution in order to protect against haemoglobin photo-degradation, 
and is a process that takes place by step. Within minutes after UVA exposure occurs 
immediate pigment darkening (IPD), a transient pigmentation not due to new melanin 
synthesis but to photo-oxidation of pre-existing melanin and to redistribution of 
melanosomes in a peripheral dendritic location. IPD is followed by a second phase of 
tanning, the persistent pigment darkening (PPD). PPD appears as brown coloration and is 
thought to result from the oxidation of melanin (like IPD), occurs within hours after UV 
exposure and persists at least 3–5 days. The last phase of skin tanning is the delayed 
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tanning (DT), can be induced by UVB or UVA and becomes apparent 2–3 days after UV 
exposure. DT is caused by increased tyrosinase activity and then production of new 
melanin, are involved also increase in the number of melanocytes, melanosomes, and the 
number of melanosomes transferred to keratinocytes. Tanning is determined directly by the 
response of melanocytes to UVR, but is also affected indirectly by a complex system of 
paracrine and autocrine factors such as hormones, cytokines and growth factors, whose 
synthesis in epidermal cells is influenced by UVR.14 
Another mechanism of protection against UV rays is skin thickening; UV rays exposure is 
immediately followed by the appearance of keratinocyte apoptotic cells, but 48–72 h later 
occurs keratinocyte hyperproliferation, that leads to an increase in epidermal thickness and 
particularly to an increase in the stratum corneum thickness. The production of melanin is 
the most important defence of the organism against UV rays, but also skin thickness of the 
stratum corneum or of total epidermis contributes to reduce the radiation amount reaching 
the epidermis basal layer and the dermis.15 
A further visible result of sun exposure is photoaging, which is due to chronic sun damage 
and contributes to accelerate the intrinsic ageing process. The injuries of UV radiation 
exposure varies depending also on ability to block or repair sun induced damages; 
generally fair–skinned persons are the most affected by photoaging and develop also areas 
of total depigmentation owing to absence of melanocytes probably destroyed by UV 
radiation. Generally, photoaged skin appears with deep wrinkles, laxity, a leathery 
appearance with coarse skin texture, enlarged pores, impaired wound healing and marked 
telangiectasia with an increase in number and diameter of small blood vessels. Both UVB 
and UVA radiation contribute to photoaging and then are interested epidermis as well as 
dermis for direct effects or for the over-stimulated production of reactive oxygen species.  
UV-generated reactive oxygen species seems responsible for mitochondrial DNA 
mutations, protein oxidative modifications, within collagen is particularly affected by 
oxidation and degradation that is carried out by matrix metalloproteases; the synthesis of 
these enzymes increases following signalling pathways initiated by reactive oxygen 
species. In addition, the large collagen degradation products inhibit new collagen synthesis 
and thus, collagen degradation itself negatively regulates new collagen synthesis and then 
interstitial collagen are reduced and damaged. Photoaged skin is also characterized by a 
reduced number of anchoring fibrils connecting the epidermis with the dermis and by an 
increase in the thickness of the horny layer and in general of epidermis and dermis, while 
intrinsically aged skin is atrophic. A typical feature of photoaging is elastosis, clinically the 
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skin shows yellow discoloration and coarse surface; histologically the dermis displays an 
overgrowth of degraded elastic fibers, organized in tangled masses, and an increased 
amount of ground substance, largely composed of glycosaminoglycans and proteoglycans. 
In photoaged epidermis keratinocytes can be irregular with a loss of polarity, a disorder 
know as actinic keratosis, clinically perceived as red, rough, hyperkeratotic patches; actinic 
keratosis has been demonstrates as the initial lesion that can progress to invasive squamous 
cell carcinoma.16,17,18 
Within skin there is the urocanic acid, a chromophore synthesised in keratinocytes by 
deamination of histidine, which is accumulated in epidermis because here there aren’t 
catabolic enzymes and then it is removed only by monthly cellular skin renewal or by 
dissolution in sweat. This molecule exists in two isoforms; trans-urocanic acid is the 
predominant cutaneous isoform, but upon UV exposure isomerizes to cis-urocanic acid and 
the isomerization ratio increases with UV dose. The photoisomerization from trans to 
cis-urocanic acid is of particular importance because cis-urocanic acid is believed to be 
responsible for photo-immunosuppression. Urocanic acid sensitizes and reacts with singlet 
oxygen species and also reacts with biomolecules such as proteins and DNA; the 
interaction with DNA involves the formation of cyclobutane adducts of urocanic acid with 
thymine and the production of pyrimidine dimers and strand breaks, that are implicated in 
immunosuppression.19,20  
Acute and chronic immunosuppression is caused by both UVB and UVA exposure and 
is dose dependent. It is believed that the decrease of immune response, observed after UV 
irradiation, serves to prevent excessive inflammation reaction and damages to the skin 
following sun exposure. The drawback of this physiological response is the suppression of 
cell-mediated immunity, result of functional inhibition of Langerhans cells, which leads to 
an impaired immune defence against neoplastic cells or infectious agent. Furthermore, 
immunosuppression is not merely an event limited to the skin, but UV radiation suppresses 
also immune response in internal organ inducing release, by keratinocytes, of 
immunosuppressive mediators such as cytokines that enter in the circulation.13,21 
The most detrimental consequence of exposure to sunlight is skin cancer; broad-spectrum 
UV radiation is listed within human carcinogens in the report on carcinogens, while UVB 
and UVA radiations are classified as “reasonably anticipated to be a human carcinogen”.22 
Many of the adverse effects of UV radiation can be attributed to DNA damage; while 
UVB, implicated as primary mutagen, is absorbed directly by DNA inducing base 
structural DNA damage, UVA is mainly responsible for indirect DNA damage by 
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generation of reactive oxygen species. Photolesions, with potentially mutagenic properties, 
induced by UVB are dipyrimidine lesions that include cyclobutane pyrimidine dimers 
(CPD), especially thymine dimers, and pyrimidine (6-4) pyrimidone photoproducts (64PP). 
The CPD are the most abundant and probably the most cytotoxic lesions as they block 
transcription and replication; if not repaired, they can lead to misreading of the genetic 
code, mutations and cell death. UVA rays also can promote the formation of CPD in 
keratinocytes and melanocytes in vivo, but requires higher doses than UVB, then UVA 
rays mainly act inducing indirect damage via absorption by other endogenous 
chromophores that can generate reactive oxygen species with consequently production of 
DNA strand breaks and mutagenic changes to purines as formation of 8-oxo-7,8-dihydro-
2’-deoxyguanosine. Cells have several DNA repair mechanisms to maintain genetic 
integrity, including nucleotide excision repair, however, the corrections are not always 
faithful to the original, irreversible defects can occur leading to mutagenesis. Furthermore 
cells can only manage low amounts of DNA damage, when DNA damage reaches critical 
levels repair systems can be overloaded and fail. The consequences of such transient or 
definitive modifications can be the inability to read and transcribe the vital messages (cell 
death caused by genotoxicity) or to misinterpret genes, the last occurrence can lead to an 
abnormal behaviour of the cells, such as hyperproliferation. When DNA mutations interest 
oncogenes and tumour suppressor genes, they can loose their function; in example p53 is a 
tumour suppressor gene that accumulates and is activated as a transcription factor, in 
damaged cells, driving a chain of events that culminates in cell cycle arrest or apoptosis. If 
p53 undergoes mutation, the ability to manage DNA repair and to remove highly damaged 
cells get lost, facilitating further mutations and enhancing tumour development. Mutation 
of p 53 is thought to be the first step in induction of nonmelanoma skin cancer.  
The three main types of skin cancers are melanoma and nonmelanoma skin cancer that 
comprises basal cell carcinoma and squamous cell carcinoma. The cutaneous malignant 
melanoma stems from melanocytes, it is the most aggressive type of skin cancer since it 
can metastasise very quickly and is the most responsible for skin cancer death; fortunately 
it is the least widespread types of skin cancer. The nonmelanoma skin cancers, deriving 
from keratinocytes, are less aggressive than melanoma; however, they can grow invasively 
and squamous cell carcinoma can also metastasise, event that occurs very rarely for basal 
cell carcinoma. People who sunburn easily and never tan have the highest risk of develop 
all three types of skin cancer; amongst white Caucasians basal cell carcinoma is the most 
common, followed by squamous cell carcinoma and at last cutaneous malignant 
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melanoma. The incidence rises increasing environmental UV exposure for all cancer types, 
but, while the occurrence of developing nonmelanoma skin cancer seems increase with the 
long-term chronic UV exposure, the risk of developing melanoma skin cancer enhances 
with acute intermittent UV exposure.23,24,25,26,27 The low incidence of cutaneous 
malignancies in darker-skinned persons is primarily a result of photoprotection provided 
by high amounts of melanin, indeed black epidermis transmits 7.4% of UVB and 17.5% of 
UVA rays, compared with, respectively, 24% and 55% for caucasian epidermis. Dark skin 
transmits less ultraviolet light thanks to the larger and more melanized melanosomes hat 
absorb and scatter more light energy than the smaller, less melanized melanosomes of 
white skin.28 
Maybe the only useful effect of UV rays is the induction of vitamin D synthesis; in fact, 
humans depend on sun exposure to satisfy their requirements for vitamin D because very 
few foods naturally contain vitamin D and only few foods are fortified with vitamin D. 
During exposure to sunlight, 7-dehydrocholesterol, which is present in the skin plasma 
membranes of both epidermal keratinocytes and dermal fibroblasts, absorbs solar UVB 
radiation and is converted to previtamin D3 that undergoes thermally induced 
transformation to vitamin D3 (cholecalciferol). Once formed, vitamin D3 is metabolized in 
the liver to 25-hydroxy-vitamin-D3 and then in the kidney to its biologically active form, 
1α,25-dihydroxy-vitamin-D3 (calcitriol) that regulates mainly calcium homeostasis.29 
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 2. UV Filters  
 
 
In the Cosmetics Directive 76/768/EEC, annex VII, the council of the European 
communities defines UV filters as substances which, contained in cosmetic sunscreen 
products, are specifically intended to filter certain UV rays in order to protect the skin from 
certain harmful effects of these rays and the filters may be added to other cosmetic 
products within fixed limits and condition.30 
The sunscreens classification changes worldwide, while in Europe they are included in 
cosmetic category, in USA, in example, they are categorized as OTC31 and in Australia the 
products labelled as protecting the skin from certain harmful effects of the sun’s UV rays 
are regulated as therapeutic goods.32 Furthermore differ the list of permitted UV filters; 
currently in Europe 26 molecules are permitted, in Australia 29 actives and in USA only 18 
molecules are authorized, also the maximum allowed concentration of active agents shows 
variation among national regulatory agencies.30,31,32 
Aside the classification of legislative guidelines, the task of sunscreens remains the same 
and therefore to shield the skin against acute and long-term UV-induced damages. To 
provide suitable protection an UV filter should: 
ü Absorb radiation in both UVB and UVA range; 
ü be photostable;  
ü be stable to heat; 
ü be chemically stable and inert to other cosmetic ingredients; 
ü be photochemically inert; 
ü posses a large molar extinction coefficient; 
ü not show cytotoxicity and phototoxicity; 
ü not penetrate through the stratum corneum but remain on the skin surface30,33,34 
Generally a single molecule can’t satisfy completely the above mentioned requirements, in 
particular it can’t ensure a broad spectrum photoprotection, because most of the molecules 
are or UVB filter or UVA filter; to overcome this problem sunscreen formulations never 
contain a single UV filter but a combination of active ingredients, where it can find 
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associations of organic filters or organic filter and inorganic filters. 
 
 
2.1 Inorganic UV filters 
Inorganic UV filters, also called physical filters, work reflecting or scattering visible, UV, 
and infrared radiation. Common agents for inorganic sunscreens are zinc oxide, titanium 
dioxide, silicates and iron oxide, nowadays the most used and authorized by competent 
authorities are zinc oxide (ZnO) and Titanium dioxide (TiO2), in Europe only Titanium 
dioxide are permitted in sunscreen formulations.30,35  
These actives are photostable, have low allergenic and sensitizing potential, but they are 
often cosmetically unacceptable because of occlusiveness and production of an opaque and 
white appearance on skin, due to high refractive index of both ZnO (refractive index = 1.9) 
and TiO2 (refractive index = 2.6); the last one with its higher refractive index cause a 
greater whitening appearance because of higher reflexion of visible light. To reduce 
reflection of visible light and give at cosmetic formulations a more transparent appearance, 
the particles of inorganic sunscreens were micronized. Micronized titanium dioxide has an 
absorption profile greater in UVB than micronized zinc oxide, whereas zinc oxide 
provided a more effective UVA protection (up to 380 nm) than titanium dioxide; the 
photoprotection range shifts in function of particle size and micronization causes shift 
towards smaller wavelengths. The greatest UV absorption/scattering properties of titanium 
dioxide are afforded with particles size between 20 nm to 30 nm, while zinc oxide particles 
provide better UV protection in the range from 60 nm to 120 nm.36  
The particles micronization causes changes in behaviour of the materials, indeed optical, 
mechanical and electrical properties are different from their conventional-sized 
counterparts; for this reason there is a growing concern regarding the safety profile of 
personal care products containing nanomaterials, in particular there are questions regarding 
the dermal penetration potential, systemic absorption and subsequent toxicity. However, in 
vitro and in vivo studies using murine, porcine, or human skin have shown that the nano-
sized TiO2 and ZnO don’t go beyond the stratum corneum and the level of penetration are 
the same of the macrosized counterparts.36 
The micronized particles not only reflect and spread light but also at the same time absorb 
the radiation, in this way the electrons of the metallic oxides are mobilized by absorption 
of UV radiation, leading to the production of reactive oxygen species, causing DNA 
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damages. To overcome the problem related to photocatalytic activity, titanium dioxide is 
coated with dimethicone or silica, this reduce the free radical formation and at the same 
time allows to keep microparticles in dispersion, since, due to electrostatic effects, 
nanomaterials tend to agglomerate resulting in loss of the efficacy of the formulation. 
Despite the concern regarding the microparticles, the inorganic sunscreens are considered 
safer then organic sunscreens and are preferred for the children and in patients with a 
history of sunscreen allergy. 37,38  
 
 
2.2 Organic UV filters 
The general structure of organic UV filter consists of an aromatic ring conjugated with an 
electron-receiving group or a double bond and substituted in ortho or para position with an 
electron-releasing group (Fig 2.1).  
  
 
 
Figure 2.1 General structures of organic UV filters. 
These molecules absorb ultraviolet radiation and tend to delocalize electrons to reach a 
higher energy state, then the excited molecules returns to the ground state emitting energy 
lower than that absorbed; if loss of energy is great, the emitted radiation lies in infrared 
region, whereas if a minor quantity of energy is lost the emitted radiation stays in the 
visible range and are perceived as either fluorescent or phosphorescent effect.3,35 
Unfortunately, sometimes after energy absorption the UV filters can undergo structural 
transformation (cis-trans or keto-enol photochemical isomerization with consecutive λmax 
shift) or even worse degradation, resulting in activity loss; these molecules are defined as 
photo-unstable. Another undesirable condition is the photoreactivity of the filtering 
molecules that is the interaction of the molecule in its excited state with oxygen or 
surrounding biomolecules of the skin, leading to the production of dangerous reactive 
species.3,34 
Y X C O
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Organic filters absorb radiation energy within a specific range of wavelength, depending 
on their chemical structure, then on the basis of the lambda maxima and of bandwidth of 
absorption spectrum they can be divided in UVB, UVA and broad-spectrum filters. 
 
2.2.1 Organic UVB filters 
UVB filters mainly absorb radiation in the wavelengths region between 290 nm and 320 
nm; several molecules are permitted for use in sunscreen formulation and they can be 
divided in different groups according to their chemical structure. 
ü PABA and its derivatives (fig 2.2). Para-aminobenzoic acid (PABA) was one of the 
first widely available UV filter, it is water-soluble and its peak absorption wavelength 
is 283 nm. The presence on the aromatic ring of an electro-releasing group (-NH2) in 
para position respect to the carboxylic acid allows an efficient electrons delocalization; 
however, at the same time the two polar groups in these positions cause problems that 
have contributed to make the product less attractive for the formulation, because amine 
and acid tend to form intermolecular hydrogen bond leading to increased association of 
the molecules and consequent dissolution problem in the cosmetic vehicles. Moreover 
PABA can make hydrogen bonds with polar emollients too, this solvent effect leads to 
shift of λmax from 293 nm in non polar solvent to 266 nm in polar solvent.3 Through 
hydrogen bonds with the protein of the keratinocytes, PABA also clings to skin cell, 
this quality makes its an ideal water resistant UV filter; however same problem about 
PABA have limited its use, actually up to 4% of the population have photoallergic 
reaction to it and consumers dislike it for staining effects on clothing.36,38 To overcome 
the above mentioned problems with PABA and to avoid that pH changes led absorption 
spectrum variations, due to the presence of free amino and acidic groups, PABA 
derivatives were designed with both moieties protected.3 The only PABA ester 
approved for use by the FDA is Padimate O, or octyl dimethyl PABA (2-ethylhexyl 4-
dimethylaminobenzoate), it maintains high UVB filtering activity (λmax 311 nm) and 
the ability to sticks to keratinocytes, keeping water-resistant properties, like the lead 
compound, but fortunately with less photoallergenic potential and it is easily to 
incorporates into cosmetic products.38 In Europe and Australia another PABA 
derivative is permitted, the PEG-25 PABA (4-bis(polyethoxy)para-aminobenzoic acid 
polyethoxyethyl ester), a water soluble UVB filter.30,32 
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Figure 2.2 PABA derivatives 
 
ü Cinnammates (fig. 2.3) have an unsaturation between the aromatic ring and the 
carbonyl portion, members of this class are: Octinoxate (2-ethylhexyl-p-
methoxycinnamate), Cinoxate (2-ethoxyethyl-p-methoxycinnamate), Octocrylene (2-
cyano-3,3-diphenylacrylic acid 2’-ethylhexyl ester), Amiloxate (isopentenyl-4-
methoxycinnamate); they have good UVB filtering capacity and low skin irritancy 
potential. Octinoxate is the most commonly used cinnamate worldwide, it has a high 
molar extinction coefficient and being insoluble in water it is suitable for water 
resistant sunscreen formulation, furthermore its systemic absorption is insignificant 
after whole-body topical application, estimated nearly 0.002%.3,38 On the other hand 
Octinoxate after irradiation undergoes cis-trans isomerisation with consequently loss of 
UV absorption efficacy in a short time, it is also reported photoinstability of the filter if 
used together with Avobenzone (UVA filter), it seems that the photoinstability of 
Avobenzone may cause the photolysis of the Octinoxate affecting the overall UV 
protection.36,39 The Octocrylene is the latest molecule approved of this group; it has 
broad UVB spectrum (peak absorption at 307 nm), but low extinction coefficient so to 
increase SPF value it is used in association with other UV filter. In the past, this agent 
was not widely used because of its cost and difficulty in formulation, but the finding 
that is the best available photostabilizer for Avobenzone has increased the use.3,36 
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Figure 2.3 Cinnammates 
 
ü Salicylates (fig. 2.4) are ortho-disubstituted compounds and their spatial arrangement 
permit intramolecular hydrogen bond, making thus electrons less available for 
interactions with biological molecules and with other ingredients of the formulation, 
this contributes to give stability to the filter and an excellent safe profile. They were the 
first available UV filters, this group include: Homosalate (3,3,5-trimethylcyclohexyl 2-
hydroxybenzoate), Octyl salicylate (2-ethylhexyl salicylate), Trolamine salicylate 
(triethanolamine salicylate). Their absorption maximum range is between 300 nm and 
310 nm, they are weak UVB absorber so it needs high concentrations to achieve a high 
SPF, despite this, salicylates have the advantages to do not penetrate the horny layer 
and so have low sensitizing potential. Octyl salicylate and Homosalate are water 
insoluble and then they still remain on the skin after bathing and perspiration. 
Trolamine salicylate instead is water soluble and has been used in hair products.3,38  
 
 
Figure 2.4 Salicylates 
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ü Ensulizole (fig 2.5) or 2-Phenylbenzimidazole-5-sulfonic acid (PBSA) is widely used 
in sunscreen formulations and because of its strong absorption in the UVB region 
within 290 nm and 320 nm, it is included in the list of authorized filters in Europe,30 
USA31 and Australia.32 PBSA is a water soluble filter, this makes it desirable for the 
use in cosmetic formulation and if used in association with lipophilic filters achieves a 
synergic increase of the sun protection factor. It is considered efficient to prevent 
erythema and safe, because few events are reported of skin irritation, sensitization 
phototoxicity or photoallergy.38 Even though PBSA protects skin cells from UVB 
radiation and is considered photostable, studies have assessed that it can generate 
reactive oxygen species and cause photoinduced damage to DNA in vitro. PBSA was 
found to induce the production of singlet oxygen, as demonstrated by the generation of 
the diagnostic compound 4,8-dihydro-4-hydroxy-8-oxo-2′-deoxy-guanosine when it is 
irradiated with UVB or natural sunlight in oxygenated solution in the presence of 2′-
deoxyguanosine, and to photoinduce the formation of alkali-labile cleavage sites in 
both single and double-stranded DNA. Although no phototoxic effects have yet been 
reported in vivo for PBSA, its proven capacity to generate singlet oxygen upon UV 
irradiation could be a threat of oxidative damage to adjacent skin tissue and to cell 
membranes, but nuclear DNA molecules would be at risk only if PBSA was able to 
enter the cells.40,41 
 
Figure 2.5 Ensulizole  
ü Camphor derivatives have a high molar extinction coefficient (> 20.000) and absorb 
in the UVB range within 290-300nm, they are considered rather photostable, because 
upon irradiation they undergo cis-trans photoisomerisation but it is reversible and the 
two isomer have similar spectra, then photoprotective ability doesn’t change 
significantly.42 In Europe six camphor derivatives are approved for the use in sunscreen 
formulation, instead Food and Drug administration has approved only Ecamsule (UVA 
absorber) and Enzacamene (4-methylbenzylidene camphor) is waiting for approval.30,31 
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Figure 2.6 Enzacamene 
 
2.2.2 Organic UVA filters  
UVA filters essentially absorb wavelengths between 320 and 400 nm; most of 
commercially available filters provide excellent protection against UVB but they are 
ineffective against UVA and there aren’t on market as many molecules effective against 
UVA; moreover usually these filters absorb in UVA II region (320-340 nm) and only few 
molecules provide protection in the UVA I range (340-400 nm).4 Within UVA filters are 
included different classes of molecules. 
ü Benzophenones (fig. 2.7) are aromatic ketones with a relative broad absorption profile 
that goes from 270 to 350 nm, hence they are active against UVB and UVA II rays. 
There are three benzophenones: Oxybenzone, Sulisobenzone, and Dioxybenzone, 
Oxybenzone mainly offers protection toward UVA II rays, it is the most commonly 
used although it presents some drawbacks as high incidence of contact photoallergic 
dermatitis, systemic absorption and it is also photounstable, initiating free radical 
production upon UV exposure.31,43 
  
 Figure 2.7 Benzophenones 
ü Anthranilates or ortho-aminobenzoates are among the oldest available UVA filters, 
they may absorb up to about 350 nm.44 The absorption spectrum in the UVA region is 
principally due to the presence of two functional groups in ortho, which can easily 
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delocalize the electrons, but at the same time the ortho disubstitution is responsible of 
the low molar extinction coefficient of these filters. They are considered stable and safe 
compounds and in cosmetic formulations don’t exhibit significant solvent shift effects. 
The filter most commonly used of this category is Meradimate (Methyl anthranilate), 
its lambda maximum is 340 nm in ethanol and it is mainly a UVA II filter.45 
NH2
O
O
MERADIMATE
2-Amino-benzoic acid 
2-isopropyl-5-methyl-cyclohexyl ester 
Figure 2.8 Meradimate 
ü Dibenzoylmethanes or substituted diketones are a relatively new class of UV filters; 
only one molecule of this group, Avobenzone (butyl methoxydibenzoylmethane) is 
permitted for use; in Europe was permitted also 4-isopropyldibenzoylmethane but in 
1993 was withdrawn from the market because of high associated incidence of contact 
and photocontact dermatitis.44 Avobenzone exhibits absorption properties resulting 
from keto-enol tautomerism, the two structural isomers have their own maximum 
absorption peak; the keto form absorbs in UVC range from 260 to 280 nm while the 
enol form absorbs in UVA range within 310 and 400 nm, with peak absorption around 
360 nm. The relative amounts of the isomers are solvent dependent but usually in 
solution and in sunscreen formulations Avobenzone exists predominantly in the enol 
form and then it can provide good protection against UVA mainly in UVA I range. 
Unfortunately this filter is photounstable, upon irradiation photoisomerisation occurs 
from the enol to keto form with consequently absorption loss46; in one hour of sun 
exposure it undergoes 50-60%.photodegradation37 Avobenzone is also able to generate 
free radicals after irradiation and in vitro studies proved that it can cause DNA strand 
breaks and oxidative protein damage.46 As said above, the photoinstability of 
Avobenzone can affect the stability of the others filters present in the formulation 
leading to complete loss of activity of sunscreen formulation; as a consequence, greatly 
efforts have been made to stabilize this compound and on market there are stabilized 
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formulation where Avobenzone is formulated with other sunscreen ingredients such as 
Octocrylene and Oxybenzone with diethylhexyl 2,6- naphthalate ( non-filter).38  
O
O O
AVOBENZONE
1-(4-tert-Butyl-phenyl)-3-(4-methoxy-phenyl)-
propane-1,3-dione  
 Figure 2.9 Avobenzone 
ü Ecamsule (terephthalylidene dicamphor sulphoic acid) is a camphor derivative, a 
broad-spectrum UVA filter with an absorption profile ranging from 290 and 390 nm 
and peak absorption at 345 nm. It is photostable and has low systemic absorption, less 
then 1% of the compound passes through the horny layer. In keratinocytes irradiated 
with UV rays it prevents DNA breakage, pyrimidine dimer formation and p53 protein 
expression compared to unprotected cells and in clinical studies, Ecamsule have 
demonstrated to prevent photodermatoses, to block UV induced pigmentation and 
immunosuppression and to preserve skin elasticity slowing down photoaging.47 
 
Figure 2.10 Ecamsule 
 
2.2.3 Organic broad-spectrum UV filters 
An ideal UV filter should provide a widespread protection against damaging UV rays, 
however only few of available molecules are able to filter effectively both UVA and UVB 
rays. These filters are the new generation of UV absorbers and are permitted in Europe and 
Australia, while in the USA are waiting for approval from the FDA via the Time and 
Extent Application (TEA) process.  
HO3S O
O
SO3H
ECAMSULE
{3-[4-(7,7-Dimethyl-3-oxo-4-sulfomethyl-bicyclo[2.2.1]
hept-2-ylidenemethyl)-benzylidene]-7,7-dimethy
l-2-oxo-bicyclo[2.2.1]hept-1-yl}-methanesulfonic acid
2. UV Filters 
 23 
ü Methylene-bis-benzotriazolyl tetramethylbutylphenol, known under the trade name 
of Tinosorb M (Ciba Specialty Chemicals, Basel, Switzerland), is a broad-spectrum 
UV filter with two absorption peaks at 303 nm and 360 nm. As a result of its molecular 
structure, that facilitates energy dissipation by intramolecular heat transfer and 
vibrational relaxation, it is a photostable molecule and helps also to stabilize other UV 
filters such as Avobenzone. The large size of the molecules minimizes the skin 
penetration and systemic absorption. It protects from UV rays by absorption, scattering 
and reflection because, although it is an organic filter, it behaves also like an inorganic 
one due to the micronized particles that are dispersed in the aqueous phase of sunscreen 
emulsions.36,38,48 
 
 
Figure 2.11 Tinosorb M 
ü Bis-ethylhexyloxyphenol methoxyphenyl triazine or Tinosorb S (Ciba Specialty 
Chemicals, Basel, Switzerland) is an oil-soluble filter with an absorption spectrum that 
goes from 280 to 380 nm and two absorption peaks at 310 nm and 343 nm. By the 
presence of two hydroxyl groups in ortho position, which facilitate the return of the 
molecule to ground stable state by rapid energy release, Tinosorb S is endowed with 
great stability and then, like Tinosorb M, is used to stabilize other filters.36,38 
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Figure 2.12 Tinosorb S 
ü Drometriazole trisiloxane (Mexoryl XL, L’Oréal) belongs to the class of 
hydroxybenzotriazoles, its absorption spectrum covers both UVB and UVA rays with 
an absorption peak in the UVB range at 303 nm and the other in UVA range at 344 nm. 
Two structural groups constitute this molecule: the hydroxyphenylbenzotriazole group 
that provides wide range UV absorption and siloxane chain, which renders the 
molecule lipophilic. It is a photostable filter and rarely causes intollerances.38,48 
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Figure 2.13 Mexoryl XL 
 
 
2.3 Evaluation of sunscreen formulations efficacy 
An international standard to measure efficacy of sunscreen is the Sun Protection Factor 
(SPF) that is the value for a product, determined under solar simulated radiation, defined 
as the ratio of the Minimal Erythemal Dose (MED) on product protected skin to the 
Minimal Erythemal Dose on unprotected skin of the same subject. MED is defined as the 
lowest ultraviolet (UV) dose that produces the first perceptible unambiguous erythema 
with defined borders appearing over most of the field of UV exposure, 16 to 24 hours after 
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UV exposure. The amount of test product applied to the skin shall be 2 mg/cm2 before 
spreading.49 
 
Since UVB is approximately 1000 times more erythemogenic then UVA, SPF value gives 
information on protection towards UVB and UVA II (320-340 nm) but not regarding UVA 
I (340-400 nm) and therefore SPF is of poor utility in understanding the UVA protection of 
a sunscreen. Because also UVA rays play a significant role in cellular damaging, it is 
important to establish, not only SPF value of a sunscreen formulation but, also the UVA 
protection to ensure a wide defence toward all UV radiation. Commonly used in vivo 
methods are IPD (immediate pigment darkening) and PPD (persistent pigment darkening), 
instead, for in vitro determination it is used the critical wavelength.  
The IPD response occurs during UVA exposure, appears as a transient gray-brown 
pigmentation and fades within few minutes after the exposure is completed. The threshold 
dose for the IPD response is used with and without sunscreen protection to assess the UVA 
protection index; since pigmentation develops relative early after UVA exposure the test 
response is immediate but pigmentation disappears rapidly after irradiation leading to 
evaluation errors, along with wide individual variability response.50 
PPD test is more used than IPD to verify UVA protection, it is also included in European 
Commission Recommendation to assess UVA protection. PPD is a skin response linearly 
dependent on the amount of UVA that enters the epidermis and the response is equally 
sensitive throughout the UVA range. The UVA protection factor of a product is calculated 
on the Minimal Persistent pigment darkening Dose of protected skin (MPDp) divided by 
that of unprotected skin (MPDu); MPDu and MPDp are defined as the quantity of radiant 
energy required to produce the first unambiguous pigmented reaction.  
 
The test product is applied in amount of 2mg/cm2, as for SPF test, and the UVA dose 
required to induce minimal pigmentation (MPD) is greater than 10 J/cm2 (approximately 
40 minutes of midday summer sunlight), thus also the stability of sunscreens is challenged 
during this test.51a,b  
SPF = MED product protected skinMED unprotected skin
UVA protection factor = MPDpMPDu
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The critical wavelength method is an in vitro test based on the absorption spectrum of a 
sunscreen product, measured applying the formulation on a substrate; 
polymethylmethacrylate plates are a satisfactory substrate for this method because they are 
UVR-transparent, non-fluorescent, photostable and inert to all potential sunscreen 
formulation ingredients. The critical wavelength (λc) value of a product is defined as the 
wavelength at which the integral of the spectral absorbance curve reaches 90% of the area 
under the curve from 290 to 400 nm. It is important to note that the critical wavelength 
value is based on the inherent shape of the absorbance curve, not on its peak absorbance, 
therefore is independent by application thickness of the tested sunscreen. The products 
reaching a critical wavelength of 370 nm or greater are considered broad-spectrum 
sunscreens.52,53 
The absorption spectrum measurement by means of UV spectrophotometer is also used to 
calculate the SPF in vitro.  
 
 
2.3 Regulatory and labelling  
Before became available on the market, sunscreen formulations are tested to determine the 
filtering capacity and then properly labelled, trying to give clear information on the product 
efficacy at the consumer; the competent authorities for UV filters define effectiveness tests 
and labelling, these rule may vary among countries. In USA the Food and Drug 
Administration (FDA) have recently published the latest guideline (June 2011) for testing 
and labelling UV filters, where it is given much attention to testing and labelling of UVA 
protection. In the past there were limited requirement and guideline for assessing UVA 
protection, and if a sunscreen formulation contained one or more UVA filter it was labelled 
as “broad spectrum”. In the current FDA rules, instead to measure UVA protection by 
means of persistent pigment darkening test, the in vitro critical wavelength is adopted as 
pass/fail test to evaluate the UVA or broad-spectrum protection. To pass the broad 
spectrum test the amount of UVA protection must increase as the SPF value and only 
products with a critical wavelength of 370 nm or greater can be labelled as “broad 
spectrum”. Only sunscreen products that pass the broad-spectrum test and have SPF of 15 
or higher can include the statement: “decreases the risk of skin cancer and early skin aging 
caused by the sun.”  Both in USA and in Europe the SPF is estimated by means of an in 
vivo method; European commission recommends an in vivo method, the persistent 
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pigment darkening test, also to assess the UVA protection factor in addition to critical 
wavelength method. In Europe a sunscreen product, to satisfy the minimum efficacy 
requirements, should provide a minimum UVB and UVA protection and when the SPF 
increase also the UVA protection should increase; the ratio of UVA protection, measured 
by persistent pigment darkening test, should be at least 1/3 of the SPF; moreover to ensure 
a broad protection it is recommended a critical wavelength at least of 370 nm. In USA it is 
not required in vivo tests method to evaluate the UVA protection, as FDA have identified 
disadvantages in the persistent pigment darkening test such are: the skin darkening, 
measured in this test, is mainly due to UVA II (320-340 nm), human subjects are exposed 
to high dose of UVA radiation, it is expensive and time consuming, exposure to UVA 
radiation alone does not occur in nature, the method is poor reproducible and also the 
interpretation of pigmentation can lead to valuation errors.  
Regarding labelling, the SPF number have been reduced in recent years to facilitate the 
comparison between different products, in USA values are expressed in multiples of 5 and 
about UVA protection, FDA recommends that products, providing UVB and UVA 
protection, are labelled as broad spectrum and no mention of the word UVA is allowed. In 
Europe the sunscreens are also divided within categories of protection according to SPF 
(see Table 2.1) and to attest the UVA protection all sunscreens have to display a simple 
logo: the letters “UVA” printed in a circular shape.54,55,56 
Table 2.1 European recommendation 2006 
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2.4 Sunscreens efficacy and safety 
Sunscreens provide effective defence by decreasing the amount of UV radiation to which 
biomolecules are exposed and therefore preventing both acute and chronic damages due to 
UV rays. The first visible benefit is the prevention of sunburns but they are useful also to 
prevent more detrimental consequences; indeed in vitro and in vivo studies have 
demonstrated that sunscreens protect against UV-induced photoaging, immunosuppression 
and mutations and then decrease the risk of developing melanoma and non-melanoma skin 
cancer.57 
The first step in developing a new sunscreen molecule is to assess the UV filtering capacity 
and if the molecule has a good absorption profile is then evaluated for the photostability; 
these assays are performed by means of instrumental analyses (UV spectrophotometer, 
solar simulator and HPLC analyses). When a molecule display interesting filtering profile 
and photostability, before becoming available on the market, it undergoes safety and 
efficacy testing that are very rigorous and comparable to those of dermatological drugs. 
The safety dossier for a new UV filter includes in vitro as well as in vivo investigation of 
their potential to produce local toxicity, such are irritation, sensitization, photo-toxicity, 
photo-genotoxicity, as well as systemic toxicity, such as long-term toxicity, reproductive 
toxicity, carcinogenicity and photo-carcinogenicity. The first level of safety evaluation 
consists exclusively of in vitro tests (i.e. MTT test), in order to exclude cytotoxicity on 
human and/or murine fibroblasts or keratinocytes and then, if they are non cytotoxic, 
genotoxicity assay, photo-toxicity and photo-genotoxicity challenges, irradiating the cell in 
presence of the new substance are performed. A new sunscreen should not only be devoid 
of genotoxic activity, but also demonstrate its potential to protect cells from the genotoxic 
activity of UV radiation. Another aspect to be verified is the percutaneous absorption of 
the filtering molecule, because it should remain on the surface of the skin, where it is most 
effective. Ideally, a sunscreen should impregnate the stratum corneum creating a barrier 
against UV radiation, but not penetrate into the underlying tissue; UV filters that deeply 
penetrate the skin are of little value, since they would leave the skin unprotected. 
Penetration test are performed previously in vitro by means of diffusion cells (Franz cells) 
using skin of pig, human reconstructed epidermis or human epidermis deriving from 
surgical interventions. After in vitro studies, the product is tested on animals to determine 
NOAEL (Non Observable Adverse Effects Levels) for oral or dermal administration in 
sub-chronic or chronic toxicity studies.  If, after these tests, a product is considered 
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harmless it goes to safety and efficacy trials on humans; these investigations includes 
confirming studies for absence of skin irritation, photo-irritation, skin sensitization, and 
photosensitization. Also trials for human systemic exposure dose are required, after topical 
application of an ultraviolet filter in a typical sunscreen formulation.58,59 
Although sunscreens available on the market have passed the above-mentioned clinical 
trials, it doesn’t mean that they are completely free of adverse effects or relating problems. 
They may induce adverse effects such as irritant, allergic contact reactions, photoallergy, 
and phototoxic effects; contact and photocontact sensitivity to sunscreens has been 
reviewed for filters such as PABA, padimate O, enzacamene, octinoxate, and ensulizole. 
Maybe the most important problem to resolve, regarding sunscreen products, is the 
photostability; during UV exposure some of these molecules may change spectral 
performance or act as photo-oxidants via generation of free radicals and reactive oxygen 
species or may degrade producing toxic by-products. Moreover photounstable products 
give a false sense of safety, because photoprotection is guaranteed only when the UV 
filters remain stable throughout the entire period of exposure to sunlight, but in labelling 
the sunscreens there are no informations regarding the photostability of the product. Some 
filtering molecule currently used suffers of photostability problems that can be overcome 
adding to the formulation photostable sunscreens or stabilizing agents.  
Another undesirable effects is the sunscreens penetration in the underlying tissues, since 
they can reach the circulatory system.60,61 
Sunscreen in some cases can display same adverse effects but they offer undeniable 
protection against dangerous UV rays and the benefit or potential risk in using UV filtering 
molecules is weighted against the hazard of skin exposure to a carcinogen. 
 
 
 
 
 
3. Free radicals and antioxidants 
 
 30 
 
 
3. Free radicals and antioxidants 
 
 
The skin, acting as a barrier toward the environment, is the most exposed organ to external 
agents, including ulraviolet rays. As above mentioned, detrimental effects of UV radiation 
is also due to production of reactive oxygen species, which are responsible of early ageing, 
inflammatory disorders, immunosuppression and skin cancers; for these reason free 
radicals and antioxidants are significant topics in photoprotection.  
 
3.1 Free radical and other oxidant species 
Free radicals are very reactive species, capable of independent existence that contain one 
or more unpaired electrons in the outermost orbital; the energetic situation is responsible 
for highly instability and short half-life of these substances. To gain stability, free radicals 
react with surrounding molecules subtracting electrons to form an electrons pair; in this 
way also the injured molecule becomes a free radical beginning a chain reaction. Usually 
radical reactions can be divided into three processes; the first is initiation, when occurs 
radical formation; the second is propagation, with increase of radicals production because 
of chain reaction; the last one is termination, the radical number decrease because two 
radicals combine or dismutation occurs with following formation of less reactive species. 
Human organism is subjected to the action of different kinds of oxidant species known as 
ROS (Reactive Oxygen Species) an RNS (Reactive Nitrogen Species), which comprise 
radicals and non-radical species within there are: superoxide anion radical (O2-·), singlet 
oxygen (1O2), hydroxyl radical (OH·), hydrogen peroxide (H2O2), lipid peroxyl radical 
(LOO·), nitric oxide radical (NO·), nitrogen dioxide radical (NO2·). Under normal 
condition, these species are present in small quantity during cellular activity, such as 
cellular respiration, apoptosis and immune response by macrophages and neutrophils to kill 
pathogens; unfortunately, in same situations take place an imbalance because of 
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overproduction of reactive species. Oxidative stress in human body can be enhanced by 
pathologies or external factors, among which there are: 
ü Pathologies as rheumatoid arthritis, cardiovascular diseases, neurodegenerative 
diseases (Parkinson and Alzheimer) and inflammation in general; 
ü Ischemia and reperfusion injury; 
ü Excess of transition metals, as iron and copper that promote the production of 
hydroxyl radical; 
ü UV rays and X rays, because of photooxidation; 
ü Drugs; 
ü Smoke; 
ü Alcohol abuse; 
ü Environmental pollution; 
ü Intense physical exercise, because increases oxygen consumption ; 
ü Diet too rich in proteins or saturated fats.62,63 
 
 
3.2 Cellular targets of oxidative stress 
At the base of free radicals damages there are biomolecules disruption; the essential 
cellular constituents impaired are nucleic acids, proteins, lipids and carbohydrates. 
 
3.2.1 Lipids 
Oxidative action regarding lipids can initiate a radical chain reaction, the lipoperoxidation 
that lead mainly to destruction of polyunsaturated fatty acids, which are components also 
of phospholipids of cellular membrane. Lipoperoxidation proceeds through the three steps; 
a hydroxyl radical initiate the process taking a hydrogen atom from a saturated carbon of 
the alchylic chain of the fatty acid, this becomes a radical too (L) and stabilize its 
structure through formation of conjugated diene, which are within the first detectable 
product of lipid peroxidation. In aerobic condition a fatty acid with an unpaired electron 
reacts with an oxygen molecules to generate a lipoperoxyl radical (LOO), a very reactive 
species that can undergo two different kinds of reaction.64 For molecules like arachidonic 
and eicosapentanoic acid, peroxylic group can do cyclization producing a cyclic 
lipoperoxyde that by fragmentation gives aliphatic chain with two carbonyl groups, 
producing highly reactive compounds such as malondialdehyde (MDA).65 This molecule 
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can react with free amine moieties of proteins, phospholipids or nucleic acid forming 
covalent bonds as Schiff bases; crosslinks proteins-MDA-phospholipid, protein-MDA-
protein or phospholipid-MDA-phospholipid cause loss of membrane fluidity.66  
Another kind of reaction occurs when lipoperoxyl radical (LOO) takes a hydrogen atom 
from close fatty acid, producing a hydroperoxide lipid and promoting lipid peroxidation.  
Aldehydic products, originating from lipid peroxidation, can also react with functional 
groups of the proteins, as sulfhydryl moieties causing break of peptidic bonds or formation 
of disulphide intramolecular bonds; in this way can be inactivated proteins essential for the 
cell life.  
In the last phase of lipoperoxidation take place the formation of stable compounds because 
of reaction between two radical species or by means of chain breaking substances; these 
events terminate the radical chain reaction. 
 
3.2.2 Nucleic acids 
About cellular injuries caused by reactive oxygen species, damages to DNA are the most 
harmful. Almost all altered molecules of DNA are replaced and repaired, however this 
safeguard system can fail and if modified DNA molecules were not corrected, the mutation 
could be transmitted during replication to daughter cells. Most commonly oxidative 
alterations of DNA are related to oxygen inclusion in double bond of DNA bases and sugar 
removing from bases, intermolecular DNA-DNA or DNA-protein binding.67 Pyrimidines 
(cytosine and thymine) are most sensitive than purines and can undergo saturation, ring 
open and therefore loss of aromaticity and planarity with DNA filaments distortion; 
photocatalized reactions of thymine produce thymine dimers. These DNA transformations 
are responsible for mutagenesis68, carcinogenesis69 and play a role also in aging,70 diabetes 
mellitus,71 inflammatory diseases and liver diseases72. 
 
3.2.3 Proteins 
Damages produced by free radicals to proteins can be distinguish in reversible and 
irreversible; among reversible there are oxidation of thiolic groups and of methionine, 
whereas between irreversible there are ring’s break of histidine and tryptophan and peptide 
bond hydrolyzation in presence of proline; the last event affects particularly the collagen 
because it is rich in proline and hydroxyproline. Oxidation of sulfhydryl moieties of the 
cysteine to thiyl radical can lead to dimerization or oxidation to sulphide dioxide group; 
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these changes are responsible for deficiencies in protein structure and function. The most 
damaged proteins are enzymes, as phosphofructokinases and complex I of mitochondrial 
respiratory chain that are of fundamental importance for energy production in the cells.73 
Decrease in available energy is responsible for biosynthesis reduction of new 
macromolecules (proteins, nucleic acids, and phospholipids), causing slowness in repairing 
processes of cellular constituents.   
Oxidation of membrane proteins contribute, beside lipid peroxidation, to decrease the 
fluidity of cellular membranes that cause reduced activity of enzyme and receptor proteins, 
changes in permeability and decrease in activity of ATP-ase pump for calcium transport. 
This last event results in increase of intracellular calcium (Ca2+) and potassium (K+) that 
leads to phospholipases actiovation A2, A1, C, D and diglycerides lipases; these are 
enzymes that increase membrane catabolism and then releasing of easily oxidable fatty 
acids. Proteins oxidation seems involved in pathologies such as atherosclerosis, ischemia-
reperfusion injuries and aging.74,75    
 
 
3.2.4 Carbohydrates 
Free radicals react quickly with carbohydrates removing hydrogen atoms; deoxyribose, 
ribose, proteoglycans and etheropolysaccharide (ialuronic acid) can undergo oxidative 
degradation. Proteoglycans, high weight molecules of parenchymal tissue, are particularly 
affected by oxidation and then are fragmented with consequent structural and functional 
irreversible damages.75 
 
 
3.3 Antioxidants 
Antioxidants are substances able to prevent or terminate oxidative stress and then 
following impairments to biomolecules. To prevent detrimental effects of oxidation, living 
organisms have different kind of antioxidants that are both endogenous and exogenous 
substances; the latest are especially helpful when endogenous defence are no more able to 
counteract oxidative reactions. 
On a pharmacological point of view, they can be classified in: enzymatic, preventive and 
chain-breaking antioxidants, these substances differ for their action mechanism and for 
distribution in the organism.62 
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The increasing importance of antioxidants is due to the preventive actions that they exert 
against initiation of pathologies as cancer, inflammatory diseases and cardio-circulatory 
disorder.76 
 
3.3.1 Enzymatic antioxidants 
The principal antioxidant enzymes are superoxide dismutase (SOD), catalase and 
glutathione peroxidase, they are intracellular antioxidant defences.65   
SOD accelerates about a thousand times the dismutation speed of superoxide anion; this 
reaction avoids the simultaneous presence of superoxide anion (O2
.-) and hydrogen 
peroxide H2O2, since these two molecules can react producing the hydroxyl radical an 
highly reactive species that lives only 2 nanoseconds and has a diffusion ray of 2 
nanometres. 
SOD    2O2.- + 2H+         H2O2 + O2  
Catalase enzyme promotes the production of water and oxygen from peroxide hydrogen.  
Catalase      2H2O2    2H2O + O2 
Glutathione peroxidase is an enzyme containing selenium; it removes hydrogen peroxide 
and other peroxides thanks to the reducing capacity of glutathione (GSH), a tripeptide 
formed by glutamic acid, cysteine and glycine.62 
Glutathione peroxidase   H2O2 + 2GS-H    2H2O + GS-SG 
 
3.3.2 Preventive antioxidants 
Iron and copper have a key function in the production of oxidant species, since they are 
catalysts in reactions, such as Fenton and Haber-Weiss reactions, that lead to the production 
of the hydroxyl radical (OH•), a very dangerous species.64 
 
 
 
Usually transition metals in the organism are bonded with proteins, free metals present 
consequently to cellular turnover or tissue lesions have to be quickly chelate to prevent the 
redox activity. Some plasmatic proteins like transferrin, lactoferrin and ceruloplasmin are 
 
 
 
Fenton  reaction    Fe2+ +  H2O2     OH•  +  OH-  +  Fe3+ 
Haber-Weiss reaction  O2.- +  H2O2     OH•  +  OH-  +  O2 
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preventive antioxidants and have the task of chelating and carrying metals. Also other 
substances are able to chelate metals, such as polyphenols77 or deferoxamine, a drug with 
high chelating capacity used in thalassemia treatment.64 
 
3.3.3 Chain-breaking antioxidants 
The chain-breaking or radical scavenging antioxidants sacrifice themselves reacting with 
free radicals before that biomolecules were damaged. The removal of an electron from the 
antioxidant transforms this molecule in a radical too, however, this event doesn’t results in 
a radical chain reaction because the oxidation product can stabilize its structure 
delocalizing the electrons and then it is not enough active to initiate a chain reaction.  
Radical scavenging antioxidants can be divided in hydrosoluble as ascorbic acid and 
liposoluble as tocopherol and carotenoids.  
Vitamin C or L-ascorbic acid is the main aqueous phase antioxidant in the body and one 
of the first defence lines against oxidative damages in plasma. It acts by stepwise donation 
of electrons; the subtraction of one electron leads to formation of ascorbate free radical that 
is a stable radical and can still works as free radical scavenger donating a second electron. 
The last resulting oxidation product is dehydroascorbic acid that can be regenerated by 
dehydroascorbate reductase.62 Virtually all plants and animals synthesize L-ascorbic acid, 
human are an exception because they have lost this ability as result of mutation that had 
lead to function loss of L-gulono-y-lactone oxidase and then humans must take L-ascorbic 
acid through diet.78 
 
Figure 3.1 L-ascorbic acid 
Vitamin E is the main antioxidant in lipid phase, with this term is indicated a family of 
molecules that can be divided into two groups: tocopherols and tocotrienols. The mole- 
cules consist of a hydrophobic phytyl chain and a chroman head; the tocopherols have 
saturated tails whereas tocotrienols have three isolated double bonds in their phytyl chain. 
Both tocotrienols and tocopherols consist of four isomers α-, β-, γ- and δ-, which differ 
from one another for the chroman ring that varies in number of methyl substituents and for 
substituted positions of the phenolic ring; α-tocopherol is considered the most active form. 
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All stereoisomers have a hydroxyl group on chroman ring in the same position, which is 
responsible for the antioxidant activity whereas the phytyl chain doesn’t seem to have any 
antioxidant activity but it is thought to be important for proper positioning within bio-
membranes. Vitamin E loses hydrogen radical from the hydroxyl group at the 6-position in 
the chromanol nucleus and it is further oxidized to dopaquinone that is devoid of 
antioxidant activity. One of the main functions of vitamin E is to prevent lipid peroxidation 
and then protect polyunsaturated fatty acid and low-density lipoproteins (LDL). In the 
organism, when vitamin E is in its oxidized form can be regenerated to its reduced form by 
L-ascorbic acid.79,80 
 
O
HO
CH3
H3C
CH3
α-tocoferolo  
Figure 3.2 α-tocopherol 
Polyphenols are most abundant and ubiquitous secondary metabolites of higher plants, 
they are mainly in present in fruits, vegetables, wine, tea, olive oil and chocolate, then 
people take them with diet.81 Within polyphenols are included heterogeneous compounds 
that differ for the complexity of molecular structure and for the number of phenolic 
hydroxyl moieties, which influence the antioxidant capacity; their high antioxidant power 
is provided by radical scavenging activity and by metal-chelating potential.82 They are 
subdivided by the structure into groups:  
1) the phenolic acids with the subclasses derived from hydroxy-benzoic acids such as 
gallic acid and from hydroxy-cinnamic acid, containing caffeic, ferulic, and coumaric acid;  
2) the large flavonoid subclass, which includes the flavonols, flavones, isoflavones, 
flavanones, anthocyanidins, and flavanols;  
3) the stilbenes within there are resveratrol;  
4) the lignans and the polymeric lignins.81 
The antioxidant activity of phenolic acids is proportional to the number of hydroxyl groups 
in the molecule and hydroxy-cinnamic acids are more effective than hydroxy-benzoic acid, 
because the electron-withdrawing properties of the carboxylate group in benzoic acids has 
a negative influence on the H-donating abilities of the hydroxy-benzoic acids.  
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Figure 3.3 Phenolic acid
Also the flavonoids activity is influenced by hydroxyls position and numbers; particularly 
important is the 3-hydroxyl group in the C ring, since the glycosylation or removal of this 
hydroxyl group causes a decrease in antioxidant capacity. Contributes to increase the 
activity also the presence of two adjacent hydroxyl moieties in ortho arrangement in B 
ring. Important for the antioxidant activity is also the unsaturation in the C ring that allows 
electrons delocalization across the molecule and then improves stabilization of generated 
radical following the action as radical scavenger of the flavonoids. 83 
OHO
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Figure 3.4 Quercetin (flavonoid) 
Polyphenols have many other biological effects that include antibacterial, anti-
inflammatory, anti-allergic, antiviral, antineoplastic, antithrombotic and hepato-protective 
activities, these actions seem to be due to their antioxidant capacity.84 
 
 
3.4 Antioxidants in skin photoprotection 
The skin has its own antioxidant defences, which include enzymatic and non-enzymatic 
antioxidants, to deal with UV-induced oxidative stress; however, excessive and chronic 
exposure to UV radiation can overcome the cutaneous antioxidant capacity, leading to 
oxidative stress and then oxidative damage that may result in skin disorders, 
immunosuppression, premature skin aging and development of melanoma and non-
melanoma skin cancers.  
Exposure to UV rays influences endogenous antioxidant enzyme levels; after a single low 
or moderate dose of UV radiation, cultured fibroblasts show an initial decrease in 
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antioxidant enzyme transcript levels, which lasts for day before enzymes (superoxide 
dismutase, glutathione peroxidase and catalase) return to basal level. Also antioxidant 
chain-breaking are depleted and without antioxidant defence the potential damaging effects 
of UV rays increase leading to an oxidative stress situation, most of all if UV exposures are 
repeated in a short time period.85 When endogenous antioxidants undercome by the 
oxidative stress, can be helpful to use antioxidant supplements. Several studies 
demonstrate that antioxidant supplements can reduce damages due to UV rays and 
following reactive oxygen species production. Usually antioxidants are present in 
sunscreen products; principally there are antioxidants scavenger such as vitamin E, vitamin 
C and polyphenols.  
Ascorbic acid has been shown to prevent erythema and sunburn cell formation after UV 
exposure, in addition it is widely used as a depigmentation agent due to its inhibitory 
action on tyrosinase and it is essential for collagen biosynthesis and may inhibit elastin 
biosynthesis and could, therefore, be useful for reducing the increased elastin accumulation 
that occurs in photoaged skin.86 One problem related to ascorbic acid is its high instability, 
indeed in topical formulation are used derivatives of ascorbic acid (e.g. magnesium 
ascorbyl-phosphate and ascorbyl-6-palmitate), however, antioxidants properties of 
derivatives are lower then parent molecule. Also topical application of  α-tocopherol has 
demonstrated a number of protective effects including reduction in erythema, photoaging, 
photocarcinogenesis, and immunosuppression. Stabilized forms of  α-tocopherol, where 
hydroxyl group on the ring is esterified, include α-tocopheryl acetate and α-tocopheryl 
succinate but both derivatives are less effective than α-tocopherol in protecting the skin 
against UV-induced erythema and have lower antioxidant power.87  
Polyphenols have good antioxidant capacities and display also other activity such as anti-
inflammatory and anticarcinogenic effects. Cinnammic acid such as ferulic acid and caffeic 
acid, applied topically, can protect against UVB-induced erythema in vivo and in vitro.88 
Particularly studied are green tea polyphenols that have demonstrated to reduce UV-
induced erythema and sunburn cells formation in human skin, when they are associated 
with UV filters.89 Furthermore, experimental data from animal models suggest that green 
tea polyphenols may reduce the incidence of sunlight-related skin cancer; oral 
administration at mice of these polyphenols in drinking water resulted in significant 
protection against UV-induced skin carcinogenesis in terms of tumor incidence, 
multiplicity and tumor size, compared to mice that were not given green tea polyphenols in 
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drinking water.90 Usually, topical antioxidants are inefficient UV filters; therefore, they are 
used in combination with sunscreens to enhance their protective efficacy. Polyphenols 
seems also effective in protecting UV filtering molecules from degradation; in example 
quercetin protects butyl methoxydibenzoylmethane and octyl methoxycinnamate from 
degradation that proceeds through the initial formation of free radicals and singlet 
oxygen.91
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UV radiation that reaches the earth surface is very dangerous and is responsible of 
detrimental effect such as erythema, photoaging, immunosuppression and skin cancers 
(paragraph 1.3). The skin is the organ most exposed and affected by UV rays, which can 
cause direct but also indirect damages to biomolecules. Direct damages are due to 
absorption of UV radiation by the biomolecules, whereas indirect injuries are caused by 
production of reactive oxygen species. Since detrimental effects of UV rays are also 
triggered by over-production of reactive oxygen species, it is important to protect the skin 
reducing the UV radiation that reaches epidermis and dermis but also trying to scavenge 
the reactive oxygen species. To this aim, our interest was in developing new compounds 
provided with both UV filtering and antioxidant capabilities.  
To proof the principle an extensive screening of commercial available molecules is 
necessary in order to start from already active molecules and improve their scavenging 
and/or filtering activity. Among the screened molecules one of the best candidates was 2-
Phenyl-1H-benzimidazole-5-sulphonic acid (PBSA), selected as lead compound for its lack 
of antioxidant activity, high water solubility and good safety profile.38 This molecule, 
commonly used in commercial sunscreen, provides a good protection against UVB rays 
but lacks of filtering capacity regarding UVA radiation and, not only, it is also devoid of 
antioxidant activity and, furthermore, it seems to induce the production of reactive oxygen 
species following irradiation, thus resulting potentially harmfull.40,41 
 
 
Figure 4.1 2-Phenyl-1H-benzimidazole-5-sulphonic acid (PBSA) 
With the aim to achieve antioxidant activity, maintaining the filtering capacity, PBSA was 
modified introducing phenolic hydroxyls on the phenyl ring and also substituting the 
N
H
NHO3S
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functional group in position 5 of the benzimidazolic ring to evaluate the influence of this 
moiety on filtering and antioxidant capabilities. To assess the antioxidant power of the 
molecules in vitro tests were performed: DPPH, PCL and FRAP assays; then it was 
necessary incorporate the molecule in a standard cosmetic formulation to evaluate the UV 
filtering capacity in vitro and also to verify the antioxidant power of the finished 
formulation. The new molecules have also undergone toxicity and phototoxicity studies to 
exclude adverse effects of the new products.  
Another important issue, concerning UV filters, is the photostability; it is fundamental for 
photoprotection that a filtering molecule remains active during exposure to sunlight; 
similar UV filters, available on market, unfortunately suffer of evident photoinstability. To 
evaluate the photostability of the new molecules, cosmetic formulations containing the 
study compounds were exposed to solar simulated radiation. Since the aim of the work was 
production of UV filtering molecules provided with antioxidant capacity, only the 
molecules that show both good filtering activity and antioxidant capacity and that were 
devoid of cytotoxicity and phototoxicity were analysed, for photostability. Cosmetic 
formulations of the best compounds were then tested by accelerated stability studies. 
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In this phase of work it was considered to modify the lead compound 2-Phenyl-1H-
benzimidazole-5-sulfonic acid (PBSA) to realize molecules with good antioxidant 
capacity, but at the same time maintaining the filtering activity. To this purpose, the phenyl 
ring was modified, introducing hydroxyl functional groups, in different position of the 
ring, to enhance the antioxidant capacity, also the functional group in position 5 of the 
benzimidazole ring was changed in order to evaluate the influence of the sulfonic acid 
moiety or other functional groups on filtering capacity. Three groups of molecules can be 
identified, which differ for the substituent present in position 5 on the benzimidazole ring. 
The changes regarding the phenyl ring are the same in the three groups and within a group 
the compounds differ one from another for the position and the number of hydroxyl 
moieties on the phenyl ring.  
The first group of molecules synthesized maintains the sulfonic acid moiety in position 5 
of the benzimidazole ring, whereas the second group shows no functional group on the 
benzimidazole ring and the third group presents, instead of the sulfonic acid, the carboxylic 
acid moiety. 
The molecules used for the synthesis are shown in scheme 1. 
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Scheme 1 
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3,4-Diamino-benzenesulfonic acid o-Phenylenediamine 3,4-Diaminobenzoic acid
H
O
OH
OH
OH
2-Hydroxybenzaldehyde 4-Hydroxybenzaldehyde 2,4-Dihydroxybenzaldehyde
3,4-Dihydroxybenzaldehyde 2,3,4-Trihydroxybenzaldehyde
 
The desired molecules were synthesized following procedures described in literature, 
fitting reaction conditions to improve the reaction yield.  
Aldehydes, 3,4-diaminobenzoic acid and o-phenylenediamine were purchased whereas 
3,4-diaminobenzenesulfonic acid was synthesized by o-phenylenediamine and sulphuric 
acid 96% (scheme 2).92 
Scheme 2 
NH2
NH2
HO3S NH2
NH2  H2SO4
i
i: H2SO4
137 °C, 24 h
3,4-Diaminobenzenesulfonic acid, sulfate salto-Phenylenediamine
1
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Different reaction conditions were evaluated to obtain the desired products in good yields 
and using cheap synthetic procedures. The synthetic procedure described in literature was 
firstly investigated, the aldehyde was refluxed in DMF with 3,4-diaminobenzenesulfonic 
acid in presence p-toluene sulfonic acid to catalyze the reaction93 but this procedure 
provides very low yield and also, when the reaction was carried out in acetonitrile at room 
temperature, using HCl and H2O2 as oxidant system94 does not give product in acceptable 
quantity. Finally it was used sodium bisulfite solution (NaHSO3) to improve the reaction 
between benzaldehyde and 3,4-diaminobenzenesulfonic acid; the reactions performed in 
ethanol refluxed for 24 hours95 give desired products in good yield and purification was 
simple, by precipitating the product of interest under acidic conditions using hydrochloric 
acid solution, 1N, and filtering the suspension.  
The molecules obtained are summarized in scheme 3 
Scheme 3 
HO3S NH2
NH2  H2SO4
+
OH
OH
OH
OH
OH
OH
i : NaHSO3 , EtOH
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O i
N
H
N
R
HO3S
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1
2 3 4
5
80 °C
OH
OH
R =
6
OH
 
The same reaction strategy was adopted to synthesize the 2-phenyl-1H-benzimidazole 
derivatives (scheme 4) and the 2-phenyl-1H-benzimidazole-5-carboxylic acid derivatives 
(scheme 5), using respectively o-phenylenediamine and 3,4-diaminobenzoic acid, in place 
of 3,4-diaminobenzenesulfonic acid. 
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Scheme 4 
NH2
NH2
+
OH
OH
OH
OH
OH
OH
i : NaHSO3, EtOH
RH
O i
N
H
N
R
R =R =
R =
R =
8
10
97
80 °C
o-Phenylenediamina
OH
OH
R =
11
OH
 
Scheme 5 
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The reactive oxygen species and free radicals display different reactivity and then a 
compound can be active against an oxidant species and less effective in scavenging 
another; therefore the synthesized molecules were evaluated by different antioxidant in 
vitro assays to verify the antioxidant capacity of the molecules against different oxidant 
species and free radicals, the parent compound PBSA (2-Phenyl-1H-benzimidazole-5-
sulfonic acid) was also tested to verify the lack of antioxidant activity. 
The molecules were evaluated by means of the following assays: DPPH (1,1-diphenyl-2-
picryl-hydrazyl radical), PCL (photochemiluminescence), FRAP (Ferric Reducing 
Antioxidant Power). 
 
 
6.1 PCL Test 
Photochemiluminescence (PCL) assay joints the photochemical generation of free radicals 
with the selective detection by using chemiluminescence. The PCL is based on the photo-
induced autoxidation of luminol, mediated from the superoxide anion radical (O2•−), which 
is accompanied by intense chemiluminescence; luminol works as photosensitiser as well as 
detection reagent of oxygen radicals. Antioxidants act as radical traps, in presence of 
antioxidant molecules the chemiluminescence decrease proportionally with the activity and 
the concentration of the antioxidant product. It is a sensitive assay, able to measure the 
scavenging activity of antioxidants against the superoxide radical in the nanomolar range 
and in few minutes, reducing the activity lost due to the degradation. 
PCL is suitable to measure the radical scavenging properties of single antioxidants as well 
as more complex systems and the assay can be conducted by two different protocols, ACW 
(Antioxidant Capacity of Water-soluble substance) and ACL (Antioxidant Capacity of 
Lipid-soluble substance), which permit the measurement, respectively, of the antioxidant 
capacity in water-soluble and lipid-soluble phase. In the ACL method Trolox (bioactive 
portion of vitamin E) is used as standard, whereas for the ACW method the standard 
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molecule is the ascorbic acid.96,97,98 The products antioxidant capacity was evaluated 
employing the ACL method and the results are expressed in micromoles of Trolox per 
millimoles of sample. 
 
Figure 6.1 Trolox 
 
6.2 DPPH Test 
DPPH (1,1-diphenyl-2-picryl-hydrazyl) radical is a stable nitrogen-centred free radical, 
characterized by absorption maximum at 517 nm that decreases in the presence of H-donor 
molecules. This radical is characterized by a deep purple colour that fades in the presence 
of an antioxidant agent; the absorbance decrease, produced by reduced DPPH radical, is 
used to evaluate free radical scavenging capacity of pure compounds or complex mixture. 
The antioxidant ability of a product is calculated by measuring the inhibition ratio of initial 
concentration of DPPH radical at 517 nm, after reaction of the radical solution with a 
solution of antioxidant products. The antioxidant activity of the tested molecules is 
expressed in micromoles of Trolox per millimoles of sample.99 
 
Figure 6.2 DPPH radical 
 
 
6.3 FRAP Test 
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1,1-diphenyl-2-picryl-hydrazyl radical 
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This method was developed by Benzie and Strain to measure plasma antioxidant power;100 
later it was employed also to analyse the antioxidant power of molecules and extracts. 
FRAP (Ferric Reducing Antioxidant Power) assay is based on the reduction in acid 
condition of ferric ion (Fe3+) to ferrous ion (Fe2+) in presence of TPTZ (2,4,6-tripyridyl-s-
triazine). In presence of an antioxidant the ferric-tripyridyltriazine complex is reduced to 
ferrous complex, the chemical reaction of FRAP method is the following: 
 
The complex with Fe3+ show a yellowish colour; when an antioxidant solution is added to 
the iron (FeIII) complex solution it develops a blue colour due to reduction at ferrous ion, 
which in complexed form with TPTZ give absorption maximum at 593 nm. Absorbance 
increase, measured at lambda maxima, is proportional to reducing power of the antioxidant 
present in solution.101 Also in this test, the standard used for the calibration curve is Trolox 
and then results are given as micromoles of Trolox per millimoles of sample. 
 
 
6.4 Results 
The results of the antioxidant assays are presented in table 6.1; the molecules tested are 
compared for the antioxidant capacity in three different antioxidant assays. The lead 
compounds PBSA was test too; in DPPH and PCL analyses the activity of PBSA is not 
evaluable because comparable to values of blank. Only in FRAP assay PBSA presents a 
minimal activity, but not significative,, therefore it could be confirmed the antioxidant 
activity lack of this product.  
The antioxidant power of the new synthesized molecules varies according to the number 
and position of hydroxyl moieties on the phenyl ring; changing hydroxyls on the ring 
changes the order of magnitude of antioxidant capacity, whereas the functional group in 
position 5 of benzimidazolic ring influences only slightly the antioxidant activity. 
Compounds with only one phenolic hydroxyl, in position 2 (molecules 5 and 10) or 4 
(molecules 2, 7, 14) on the phenyl ring, as expected, has the lowest antioxidant capacity in 
all performed assays. 
 
 
 
Fe(TPTZ)2(III) + ArOH Fe(TPTZ)2(II) + ArOH
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Table 6.1 Antioxidant assays 
Product 
DPPH 
µmolTrolox/mmol 
(P≤0.05) 
FRAP 
(µmolTrolox/mmol) 
(P≤0.05) 
PCL  
(µmolTrolox/mmol) 
(P≤0.05) 
PBSA < LOQ* 0,79 ± 0,06 < LOQ* 
2 2,04 ± 0,15 12,23 ± 0,25 11,36 ± 0,08 
3 2145,31 ± 45,8 2707,29 ± 29,52 22838 ± 836,26 
4 2,03 ± 0,09 16,22 ± 0,89 2,06 ± 0,05 
5 21,41 ± 0,43 19,87 ± 0,22 159,1 ± 4,3 
6 1362,12 ± 133,96 2713,3 ± 45,17 1924,35 ± 101,82 
7 1,67 ± 0,08 21,94 ± 0,12 9,66 ± 0,04 
8 1974,58 ± 16,89 2663,21± 32,53 19190,6 ± 443,18 
9 16,47 ± 0,54 37,3 ± 0,35 198,53 ± 2,65 
10 0,87 ± 0,05 23,04 ± 0,09 10,93 ± 0,05 
11 1811,02 ± 61,7 2723,19 ± 35,74 1614,675 ± 19,95 
12 1771,82 ± 84,75 2433,28 ± 21,74 13174,31± 240,68 
13 32,48 ± 2,38 31,63 ± 1,96 160,26 ± 4,09 
14 1,185 ± 0,02 2,62 ± 0,06 6,98 ± 0,27 
15 1241,03 ± 9,43 2355,15 ± 52,55 1515,65 ± 75,56 
     LOQ* limit of quantification 
 
The antioxidant activity increased adding another hydroxyl; products with two phenolic 
hydroxyls in position 2 and 4 on the phenyl (molecules 5, 9 and 13) show activity 
improvement, but best result are obtained with molecules 3, 8, 12 that have hydroxyl 
moieties in position 3 and 4 of the phenyl ring. The gap, in antioxidant power, of 
molecules that differ for the position of the two phenolic hydroxyls is very high in all 
performed tests. Compounds with three hydroxyls on phenyl ring (products 6, 11, and 15) 
do not demonstrate further improvement in antioxidant activity compared to molecules 
with two hydroxyls in position 3 and 4 of the phenyl ring; on the contrary, the results for 
DPPH test are lower then those of molecule 3, 8 and 12 and significant decrease in 
antioxidant activity is shown in PCL assay. In FRAP analysis compounds with three 
hydroxyl moieties give results comparable to that of molecules with hydroxyl in position 3 
and 4. Considering the three assays the molecule with better antioxidant profile are those 
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with two phenolic hydroxyls in position 3 and 4; in all performed tests the compound 3 has 
the highest antioxidant capacity, followed by compound 8 and 12. For products 6, 11 and 
15 with three phenolic moieties and compounds 5, 9 and 13 with two hydroxyls in position 
2 and 4 on the phenyl ring, the antioxidant capacity is decreased probably because of 
hydrogen bond formation between nitrogen of benzimidazole and the phenolic hydroxyl in 
position 2 on the phenyl ring. 
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7. UV spectra measurement 
 
 
Before proceeding with inclusion of the synthesised molecules in a cosmetic formulation, 
it was measured the UV spectrum of the compounds, because SPF is correlated with the 
UV spectrum absorption. By UV spectrum it was determined the wavelength of absorption 
maximum (λmax) and then, using solutions at different concentrations, it was calculated the 
molar extinction coefficient (ε) of every products. 
The UV spectrum of the molecules was analysed in aqueous solution and at controlled pH 
that was maintained around 7; this value was selected because at pH lower than 7 the lead 
compound PBSA (2-Phenyl-1H-benzimidazole-5-sulfonic acid) and the new molecules 
tend to precipitate and on the other hand, while basic conditions are favourable for 
compounds dissolution, they will not fit with requirement for cosmetic formulation 
because the skin has acid pH values. Considering that solvent and pH value are responsible 
for UV spectrum shift and then for UV filtering parameters variation, influencing also the 
stability of the compounds,3 the substances were measured at pH 7 because is the same 
adopted in preparation of cosmetic formulation and is a good compromise between 
cosmetic tolerability and molecules solubilisation. 
The UV spectra were recorded between 270 and 420 nm (20 nm higher and lower then 
UVA and UVB range) to verify the spectrum profile of the molecules within UVA and 
UVB region. 
In figure 7.1 is shown the UV spectrum of PBSA, it is an UVB filter and presents a λmax of 
302 nm, after this peak the absorbance fades going to higher wavelength until almost zero 
around 325 nm then it provides no absorption in the UVA region.  
In figure 7.2, 7.3 and 7.4 are shown the molecules spectra overlapped for category of 
molecules according to the substituent in position 5 of the benzimidazole ring; in all 
figures is present the PBSA spectrum for comparison. 
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Figure 7.1 PBSA UV spectrum 
 
 
Figure 7.2 Comparison between spectra of PBSA and molecules with sulfonic acid           
moiety on benzimidazolic ring: 2, 3, 4, 5, 6. 
 
 
Figure 7.3 Comparison between spectra of PBSA and molecules with no moiety on 
benzimidazolic ring: 7, 8, 9, 10, 11. 
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Figure 7.4 Comparison between spectra of PBSA and molecules with carboxylic acid           
moiety on benzimidazolic ring: PBSA, 12, 13, 14, 15 
By observation of UV spectra appears that the lambda maxima (table 7.1) of the new 
molecules shifts toward higher wavelength and in general the range of absorption curve is 
wider then PBSA. Within a group of molecules the batochromic shift is more marked for 
the molecule that have an hydroxyl moiety in position 2 of the phenyl ring (products 4, 5, 
6, 9, 10, 11, 13 and 29); the effect of ortho substituted is known to produce this shift 
toward higher wave length.3 Increasing the number of auxochrome groups on phenyl ring 
an increasing in the absorption range occurs, the products with three hydroxyl on the 
phenyl ring (6, 11, 15) have broadest spectrum and their lambda maxima shift at highest 
wavelength compared to the other compounds. The absorption spectrum of molecules with 
the same number and position of hydroxyl seems only slightly influenced by the 
substituent in position 5 of the benzimidazole ring.  
After having established the lambda maxima for every compound, solutions at different 
concentrations were prepared to calculate the molar extinction coefficient by means of 
linear regression and applying Lambert-Beer equation. 
 
 
A = sample assorbance 
ε = molar extintion coefficient 
c = concentration (mol/l) 
d = light travel (cm) 
 
A = ε · c · d 
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Table 7.1 Values of  λ max and ε 
 λ max (nm) ε 	  
PBSA 302 25000	  
2 308 25000 
3 313 23000 
4 315 21000	  
5 318 23000 
6 328 22200 
7 306 24000 
8 311 16000 
9 315 14000 
10 315 17000 
11 325 12000 
12 317 21000 
13 321 20000 
14 312 24000 
15 332 17000 
 
Extinction coefficients of new molecule have values nearby the lead compounds, excepted 
molecules 8, 9, 10, 11 (benzimidazole derivatives) and 15 that have lower molar extinction 
coefficient. 
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8. Cosmetic formulation evaluation 
 
 
The synthesised molecules were included at the concentration of 3% in a cosmetic 
formulation, to prove the effective filtering capacity and the antioxidant activity of finished 
formulation. At this purpose the compounds were included in standard formulation oil in 
water (table 8.1), lacking of antioxidant and filtering activity. The antioxidant capacity of 
emulsion was evaluated by means of photochemiluminescence assay and the filtering 
activity was verified by an in vitro method too; before proceeding it was tested the 
standard emulsion to confirm the absence of antioxidant and filtering capabilities and to 
exclude the influence of the formulation on antioxidant and filtering power. It was not 
possible to analyse the compound 7 in cosmetic formulation because it causes emulsion 
instability.  
Table 8.1 Cosmetic formulation O/W. 
Ingredients % p/p 
PHASE I 58.5                                                                          
Aqua 52.8 
Glycerin 5.0 
Phenoxyethanol, Methylparaben, Ethylparaben, 
Butylparaben, Propylparaben, Isobutylparaben 0.7 
PHASE II 20.5 
Cetyl alcohol, Glyceryl stearate, PEG-75 stearate, 
Ceteth-20, Steareth-20 6.0 
Cetyl alcohol 2.0 
Dimethicone 0.5 
C12-15 Alkyl Benzoate 6.0 
Cocoglycerides 6.0 
PHASE III 21.0 
Active ingredient  3.0 
Aqua 15.0 
NaOH solution 10% 6.0 
TOTAL 100.0 
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8.1 Analysis of filtering parameters 
The cosmetic formulations containing the active ingredients were tested by the in vitro 
method of Diffey and Robson,102 with the purpose to verify the filtering activity of the new 
molecules in comparison with the lead compound. This method is based on the measure of 
spectral transmission of ultraviolet radiation, with and without the sunscreen applied, 
through an irregular substrate that simulates the skin surface and permits transmission of 
UV radiation. The spectral monochromatic transmittance is measured, by means of UV 
spectrophotometer, in the range between 290nm and 400nm and is given by the ratio of the 
radiation transmitted by the sample to the radiation transmitted by the substrate, spectral 
monochromatic transmittance (T(λ)) is given by the following relation: 
𝑇 𝜆 = 𝑆𝑠(𝜆)𝑆𝑜(𝜆) 
Where: 
• Ss(λ)  is the transmittance of the substrate with sunscreen applied; 
• So(λ) is the substrate transmittance at the wavelength λ. 
Measuring every 0,5 nm the transmittance values within UVB and UVA range (290-400 
nm), the Sun Protection Factor (SPF) is given by the equation: 
 
• E(λ) is spectral irradiance of terrestrial sunlight that represents the midday 
midsummer sunlight for Southern Europe (latitude 40° Nord, solar zenith angle 
20°, ozone layer 0,305 cm); 
• B(λ) is the relative effectiveness of UVR at wavelength λ (nm) in producing 
delayed erythema in human skin. 
This in vitro test simulates the condition used in SPF in vivo method, both for the applied 
quantity of sunscreen on substrate (2mg/cm2) and for the interaction with the substrate. The 
test is useful to predict SPF in vivo and to screening the potential filtering activity of new 
molecules that cannot be tested by in vivo method because of lacking of more data 
concerning safety.  
∑
∑
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 In vitro SPF determination allow also to gain information about the homogeneity of the 
formulation regarding the filters dispersion and, furthermore SPF values, can be 
determined also UVA protection factor and UVA/UVB ratio.  
Measuring the UV spectrum absorbance of the formulation is also possible to calculate the 
critical wavelength (see paragraph 2.3) of sunscreen product using the following equation: 𝑅 = 𝐴𝜆𝑑𝜆𝜆𝑐290𝑛𝑚 𝐴𝜆𝑑𝜆400𝑛𝑚290𝑛𝑚  
The critical wavelength (λc) is the first value of λc for which R results equal to 0,9. 
In table 8.2 are listed the SPF, UVA protection factor (UVAPF), UVA/UVB ratio and 
critical wavelength of new molecules and PBSA. The standard formulation was also 
analysed by this method and didn’t exhibit any filtering activity. 
Table 8.2 Filtering parameters  
Formualtion SPF (P ≤ 0.05) 
UVA/UVB 
(P ≤ 0.05) 
UVAPF 
(P ≤ 0.05) λc nm 
PBSA 6.29 ± 1.09 0.31 ± 0.05 1.97 ± 0.25 333 
2 6.44 ± 0.15 0.61 ± 0.01 2.57 ± 0.07 346 
3 13.36 ± 2.24 0.88 ± 0.04 6.88 ± 1.33 358 
4 3.02 ± 0.43 1.14 ± 0.01 2.0 ± 0.23 355 
5 2.96 ± 0.64 1.35 ± 0.01 2.3 ± 0.41 370 
6 8.14 ± 0.12 1.06 ± 0.03 5.15 ± 0.08 383 
8 7.07 ± 1.20 0.93 ± 0.02 3.63 ± 0.50 368 
9 4.85 ± 0.73 1.31  ± 0.05 3.58 ± 0.50 380 
10 2.67 ± 0.44 1.20 ± 0.02 2.0 ± 0.30 378 
11 3.88 ± 0.32 1.07 ± 0.01 2.55 ± 0.1 381 
12 9.82 ± 1.30 1.21 ± 0.04 5.75 ± 0.78 370 
13 3.88 ± 0.77 1.51 ± 0.02 3.0 ± 0.52 368 
14 8.17 ± 2.13 0.83 ± 0.05 3.87 ± 0.91 350 
15 5.02 ± 1.4 1.15 ± 0.08 3.55 ± 0.88 382 
 
8. Cosmetic formulation evaluation 
 
 58 
Evaluating the filtering parameters of new molecules it can be observed that all new 
molecules have improved UVA filtering parameters, since UVA protection factor, 
UVA/UVB ratio and critical wavelength are higher than those of lead compound. The 
molecules with a phenolic hydroxyl in ortho position on the phenyl ring (compound 4, 5, 9, 
10 and 13) have the lower SPF value than parent compound but they have better 
UVA/UVB ratio and also and higher critical wavelength. Within this group is interesting 
the molecule 9 that shows a SPF of almost 5 and has a critical wavelength of 380 nm.  
Formulation containing products 2 and 14, that have a phenolic hydroxyl in para position 
on phenyl ring, have higher SPF values, greater UVA protection factor, critical wavelength 
and also higher UVA/UVB ratio than PBSA but the last two parameters are lower 
compared to the molecules with a phenolic hydroxyl in ortho on the phenyl ring. 
Interesting are compounds 3, 8 and 12, with hydroxyls in position 3 and 4, which show 
high SPF values, the best is achieved by product 3 with a SPF double than PBSA. This 
product shows also great UVA protection factor, UVA/UVB ratio and critical wavelength 
than PBSA. Molecules 8 and 12 have lower SPF than compound 3, but higher than PBSA; 
in comparison to 3, however, they present higher UVA/UVB ratio and critical wavelength. 
Regarding compound with three hydroxyls on phenyl ring, they have good UVA filtering 
parameters, their critical wavelengths are the highest and SPF is higher then PBSA for 
molecules 6, while SPF of 15 is slightly lower and decreases further in molecule 11. Also 
UV filtering parameters are principally influenced by the number and position of hydroxyl 
groups on phenyl ring, rather than the substituent in position 5 on benzimidazole ring. 
 
 
8.2 Antioxidant efficacy of cosmetic formulations 
The cosmetic formulations were evaluated also for antioxidant activity by means of PCL 
test, following the ACL method as for the pure compounds (paragraph 6.1). Besides 
antioxidant capacity of the single molecules, its is important also to verify the effective 
antioxidant ability of finished cosmetic formulation, to evaluate the activity of functional 
ingredient at the concentration employed in the formulation and also to exclude the activity 
loss because of interaction with the ingredients of the emulsion. The antioxidant power is 
given in micromoles of Trolox per gram of cosmetic formulation, results are shown in 
table 8.3; the standard formulation tested with this method did not display any antioxidant 
activity and as formulation with PBSA. 
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Table 8.3 Antioxidant activity of formulations 
Formulation 
PCL 
µmol Trolox/g formulation 
(P ≤ 0.05) 
PBSA <LOQ 
2 0,33 ± 0,03 
3 2212,09 ± 68,35 
4 0,06 ± 0,02 
5 0,95 ± 0,02 
6 101,98 ± 1,08 
8 2972,107 ± 145,63 
9 8,66 ± 0,04 
10 0,5 ± 0,02 
11 153,35 ± 8,14 
12 1373,39 ± 19,43 
13 4,97 ± 0,17 
14 0,16 ± 0,02 
15 86,99 ± 6,95 
Results of the antioxidant analysis on the finished formulations correspond to that obtained 
testing the pure compounds and then formulations containing compounds with only one 
phenolic hydroxyl (2, 4, 10 and 14) have poor antioxidant capacity, which slightly increase 
for formulation having compounds with two phenolic hydroxyl in position 2 and 4 on the 
phenyl ring (products 5, 9 and 13). Formulations with molecules 3, 8 and 12 present 
highest antioxidant capabilities; these are followed, but with important decrease in 
antioxidant capacity, by formulation with products 6, 8 and 15 that have three hydroxyl 
moieties on phenyl ring. 
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9. Cytotoxicity and Phototoxicity tests  
  
To evaluate the safety profile of the new molecules were performed, firstly, cytotoxicity 
assays to exclude negative effects of the products on cell viability and then phototoxicity 
tests under UVA and UVB radiation; because filtering molecules cannot show toxicity 
following irradiation but, on the contrary, they should provide photoprotection.  
Since sunscreen products are applied on skin, for testing we used a specific cell line of 
human keratinocytes (NCTC-2544) to evaluate both cytotoxicity and phototoxity. The 
evaluation of cell viability, in presence of the filtering molecules, without irradiation and 
after irradiation was checked by MTT test; this is a colorimetric assay that assesses the cell 
survival ratio by evaluation of the enzyme activity. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5 
diphenyl tetrazolium bromide) is a yellow dye that can be absorbed by viable cell and 
reduced by mitochondrial dehydrogenases enzymes to formazan, producing insoluble 
purple crystals. 
 
                                      
                   MTT                                                                      MTT formazan 
Figure 9.1 MTT reduction  
 
Formazan crystals are solubilized adding a solution of hydrochloric acid in isopropanol, 
after complete dissolution it is read the absorbance by means of a spectrophotometer, the 
absorbance is proportional to cell viability since only living cell can produce formazane.103 
Survival cells ratio is given by: 
 
mitochondrial 
dehydrogenases 
9. Cytotoxicity and Phototoxicity tests 
 
61 
 
Abscontrol represents 100% of survival and it is the absorbance of cell not treated with 
substance in analysis and not irradiated; Abssample is the absorbance of cell in contact with 
substance and for phototoxixity test is the absorbance of cell irradiated and in contact with 
substance in analysis. 
The cytotoxicity was checked by MTT test after 72 hours from the incubation of the 
keratinocytes with compounds, moreover, the same experiments were performed in the 
presence of the parent UVB filter PBSA. In table 9.1 are displayed cytotoxicity test results, 
expressed in IC50 (µM), which is the concentration required to inhibit 50% of cellular 
growth. 
Table 9.1 Cytotoxicity test results 
Compounds IC50 (µM) 
PBSA > 50 
2  26.4 ± 2.7 
3  > 50 
4  > 50 
 5  > 50 
6  23.1 ± 2.9 
7  26.1 ± 2.4 
8  > 50 
9  > 50 
10  > 50 
11  > 50 
12  > 50 
13  > 50 
14  > 50 
15  > 50 
 
Most compounds did not show cytotoxicity at the employed concentrations in cell line of 
human keratinocytes and their IC50 is greater then 50 µM, instead compounds 2, 6 and 7 
have IC50 value in the range between 20 and 30 µM, particularly compound 6 has the 
lowest IC50 and then is the most cytotoxic of tested compounds. 
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After cytotoxicity the molecules were verified for photocitotoxicity in the same cell line; 
the cells were treated with 50 µM solutions of compound and after 30 minutes were 
irradiated with 20 J/cm2 UVA or with UVB at two energy amounts: 0.5 J/cm2 and 1 J/cm2 
UVB. The compounds 2, 6 and 7 were used at concentration of 20 µM to avoid the 
antiproliferative effect of these compounds. After irradiation, the solution was replaced 
with grow medium and the cells were further incubated for 48 hours, then cell viability was 
assessed by MTT test. Results are presented in table 9.2 and are indicated as percentages of 
cell survival in comparison with non-irradiated cells (100% cell survival). The product 
phototoxicity is compared to cell survival ratio of keratinocytes irradiated without any 
substances (IC = irradiated control).  
Table 9.2 Phototoxicity test results 
 Compound 
concentration 
µM 
% CELL SURVIVAL 
UVA 20 J/cm2 UVB 0.5 J/cm2 UVB 1 J/cm2 
IC  69.1 ± 3.2 % 63.1 ± 3.2 % 33.8 ± 3.1 % 
PBSA 50 74.5 ± 1.4 % 75.2 ± 4.5 % 64.2 ± 3.1 % 
2  20 77.3 ± 2.8 % 78.0 ± 3.5 % 46.7 ± 3.4 % 
3  50 77.4 ± 4.0 % 71.5 ± 2.5 % 58.1 ± 2.6 % 
4  50 76.9 ± 2.0 % 74.3 ± 3.2 % 37.7 ± 1.7 % 
 5  50 79.0 ± 6.0 % 70.8 ± 3.9 % 38.6 ± 3.7 % 
6  20 18.4 ± 2.3 % 59.3 ± 3.4 % 29.7 ± 2.1 % 
7  20 72.8 ± 2.9 % 74.2 ± 1.3 % 44.0 ± 4.1 % 
8  50 62.9 ± 4.3 % 72.8 ± 1.0 % 43.9 ± 3.4 % 
9  50 3.7 ± 0.5 % 1.1 ± 0.3 % 0.5 ± 0.1 % 
10  50 4.8 ± 0.6 % 19.8 ± 2.4 % 3.5 ± 0.3 % 
11  50 1.2 ± 0.2 % 45.6 ± 2.6 % 27.0 ± 2.4 % 
12  50 74.3 ± 2.0 % 76.3 ± 3.6 % 64.5 ± 3.5 % 
13  50 80.7 ± 1.3 % 69.0 ± 0.2 % 57.5 ± 2.4 % 
14  50 76.7 ± 3.4 % 74.2 ± 3.4 % 58.4 ± 2.5 % 
15  50 12.2 ± 1.3 % 60.1 ± 2.3 % 25.6 ± 2.7% 
 
Both UVA and UVB radiation induced a clear reduction in cell survival of irradiated 
control; UVA radiation caused a decrease of about 30%, while the lower dose of UVB of 
about 35% and the higher UVB dose of 65%. When irradiation was carried out in presence 
of the compounds, some different changes in cell survival were detected; molecules 6, 9, 
10, 11 and 15 seemed to have a phototoxic effect as cell survival decrease considerably in 
9. Cytotoxicity and Phototoxicity tests 
 
63 
 
comparison to irradiated control and then these compounds are not suitable as 
photoprotective agents. All the other compounds, comprising PBSA, increase cell survival 
after UVA and UVB irradiation in comparison with irradiated control. A great increase in 
cell viability it is observed after UVB irradiation (1 J/cm2), particularly, in presence of 
PBSA and compounds 3, 12, 13 and 14 the cell survival is almost double in relation to the 
control. 
Regarding the phototoxicity test the most interesting compounds are 3, 12, 13 and 14 that 
increase cell survival both after UVA and UVB irradiation, therefore these substances 
seems suitable as filtering molecules. 
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10. Photostability and Stability studies 
 
 
Products showing the best features, in term of antioxidants and filtering capabilities, and 
that demonstrated to be devoid of cytotoxicity and phototoxicity were assayed for stability 
and photostability in cosmetic formulation. The best candidates, which have all the above-
mentioned characteristics, were compounds 3, 8 and 12. Photostability and stability studies 
were performed in the same cosmetic formulation used for the other tests and the active 
ingredient was at concentration of 3% as for the other assays. 
 
 
10.1 Photostability studies 
Photostability is an important requirement for filtering molecules, since degradation of the 
filter in sunscreen formulations lead to photoprotection loss and consequently damage to 
skin, because UV rays can reach skin in large amount and also because photodegradation 
products can be toxic.60 
Before proceeding with photostability studies, it was determined the real concentration of 
filtering molecules in the formulation by HPLC analysis. 
A portion of cosmetic formulation containing molecule 3, 8, 12 or lead compound PBSA 
was transferred in a beaker to achieve an amount of sunscreen formulation of 2mg/cm2, the 
same used to test the filtering parameters. The samples were placed under solar simulator 
device for 1 hour, after exposure the beaker was removed and the irradiated formulation 
were transferred in a calibrated flask with methanol and the concentration of tested 
molecules was quantified by HPLC. The photodegradation degree was determined by 
comparison of areas between irradiated sample and corresponding amount of non-
irradiated sample. In table 10.1 are shown analyses results of molecules 3, 8, 12 achieved 
by four independent experiments, results are given as ratio of remaining molecule. 
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Table 10.1 Remaining amount of products after solar simulated irradiation. 
Product Residual product (P≤0.05) 
PBSA 96,7% ± 1,8% 
(UV3) 3 94,9% ± 0,8% 
(UV20) 8 92,9% ± 2,6% 
(UV14) 12 98,4 % ± 0,9% 
 
After irradiation procedure the residual amount of new molecules doesn’t diverge much 
from lead compound PBSA; compound 3 degrades a little more than PBSA, whereas 
product 8 shows a higher degradation rate that, however, is low than 10%. The best result 
is achieved with compound 12 that exhibits the lowest degradation rate, less than 2% and 
therefore has better photostability than lead compound. 
 
 
10.2 Stability studies 
Molecules 3, 8, and 12 are challenged in accelerated stability studies, in comparison to 
parent compound.  Cosmetic formulations containing the compounds were analysed by 
HPLC to determine the real concentration of the active molecules before storing the 
formulations in sealed vessels and put them into oven at 40°C. The formulations were 
checked at appropriate time intervals; aliquots were taken from the emulsions and 
dissolved in methanol. In figure 10.1 are displayed results of stability studies. 
 
Figure 10.1 Stability studies of formulations 
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In accelerated stability studies the lead compound PBSA shows higher stability than its 
derivatives; the compound that degrades most quickly is product 3, followed by product 8. 
Within new molecules compound 12 is provided with highest stability and its degradation 
progression doesn’t differ much from the degradation curve of PBSA. It can be expected 
that molecules with higher antioxidant power could undergo degradation more rapidly than 
molecules without antioxidant capacity, because of their higher intrinsic reactivity. 
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11. Conclusions 
  
 
The finding that harmful effects of UV rays are not only due to direct damages, but also to 
indirect damages, caused by over-production of radical species, has highlighted the 
importance of providing a complete photoprotection by screening UV radiation but also by 
scavenging reactive oxygen species.  
Growing interest in sunscreen products, able to ensure photoprotection but also provided 
with radical scavenging activity, had led research toward production of molecules provided 
with both sunscreen and antioxidant capabilities. To this purpose, among the newly 
synthesized molecules, the most interesting were compound 3, 8 and 12, that show a good 
filtering activity and also high antioxidant power, that is maintained in cosmetic 
formulation. Generally all the new products have improved antioxidant capacity than lead 
compound. In addiction to antioxidant activity, the introduction of auxochroms on the 
phenyl ring of PBSA have shifted UV spectrum absorption toward longer wavelengths, 
indeed new compounds show a better UVA/UVB ratio and higher critical wavelength 
values then PBSA. UVA/UVB ratio is notably improved in compounds that have a 
hydroxyl moiety in position two on the phenyl ring, but these molecules exhibit also lower 
SPF than other compounds, just because of the presence of hydroxyl in ortho position that 
gives hydrogen bond with nitrogen of benzimidazole ring. Compounds that have hydroxyl 
in para position instead have a higher SPF than PBSA and also better UVA filtering 
capacity, but UVA/UVB ratio is lower than that of compounds with an auxochrom in ortho 
position. The molecules with three hydroxyl moieties on phenyl ring show absorption 
spectrum widening; considering also the lambda critical values they can be considered 
broadband UV absorber. Unfortunately, they have antioxidant capacity lower than 
molecule with two hydroxyl groups in position 3 and 4 on the phenyl ring (compounds 3, 8 
and 12) and, most of all, these compounds (6, 11 and 15) exhibit phototoxic activity on 
human keratinocytes; molecule 6 is also cytotoxic in concentration range between 20-30 
µM. Because of phototoxicity molecules 6, 11 and 15 cannot be used as UV filters.  
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Table 11.1 Filtering and antioxidant capabilities of cosmetic formulations 
Cosmetic formualtion SPF (P≤0.05) 
UVA/UVB 
(P≤0.05) 
UVAPF 
(P≤0.05) 
λc 
nm 
PCL 
µmolTrolox/g 
formulation 
(P≤0.05) 
PBSA 
 
6.2 ±1.09 0.31±0.05 1.97±0.25 333 <LOQ* 
2 
 
6.44±0.15 0.61±0.01 2.57±0.07 346 0.33±0.03 
 3 
 
13.36±2.24 0.88±0.04 6.88±1.33 358 2212.09±68.35 
 4 
 
3.02±0.43 1.14 ± 0.01 2.0±0.23 355 0.06±0.02 
5 
 
2.96±0.64 1.35±0.01 2.3±0.41 370 0.95±0.02 
6 
 
8.14±0.12 1.06±0.03 5.15±0.08 383 101.98±1.08 
(UV20) 8 
 
7.07±1.20 0.93±0.02 3.6±0.50 368 2972.107±14.63 
 9 
 
4.85±0.73 1.31±0.05 3.58±0.50 380 8.66±0.04 
 10 
 
2.67±0.44 1.20±0.02 2.0±0.30 378 0.5±0.02 
11 
 
3.88±0.32 1.07±0.01 2.55±0.1 381 153.35±8.14 
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12 
 
9.82±1.30 1.21±0.04 5.75±0.78 370 1373.39±19.43 
13 
N
H
NHOOC
HO
OH
 
3.88±0.77 1.51±0.02 3.0±0.52 368 4.97±0.17 
14 
N
H
NHOOC
OH
 
8.17±2.13 0.83±0.05 3.87±0.91 350 0.16±0.02 
 15 
 
5.02±1.4 1.15±0.08 3.55±0.88 382 86.99±6.95 
   LOQ* limit of quantification 
 
Molecules 3, 8 and 12 satisfy the requirements for goodfiltering and antioxidant activity; 
they are also devoid of cytotoxic and phototoxic effects and, in particular, products 3 and 
12 exhibit good photoprotection activity against UVA and UVB radiations, indeed, after 
irradiation in presence of these compounds it is observed an increase in cellular survival 
rate.  
These three compounds finally were testes also for stability and photostabilty; outcomes of 
accelerated stability studies suggest that they are less stable than parent compound, this 
result can be explained by the higher reactivity of molecules provided with high 
antioxidant power, however, stability of compound 12 does not differ much from PBSA. In 
photostability studies, under solar simulated condition, products 8 seems the less 
photostable but its degradation rate is, however, lower than 10%. The best results are 
achieved by compound 3, which degrades only slightly more than PBSA, and most of all 
with product 12 that shows higher photostability than lead compound with a degradation 
rate lower than 2%.  
The substituent in position 5 on benzimidazole ring does not exert significant effect on 
antioxidant power, which is mainly controlled by phenolic hydroxyls, but differences are 
observed in stability, photostability, cytotoxicity and phototoxicity of molecules 3, 8 and 
12, which differ only for the substituent in position 5 on benzimidazole ring. Carboxylic 
acid seems to provide highest stability, photostability and cell photoprotection; instead, 
compound 8, without substituent in position 5 on benzimidazole ring, has the lowest 
N
H
NHOOC
OH
OH
N
H
N
OH
HOOC
HO OH
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photostability and provides less photoprotection to irradiated keratinocytes than compound 
3 and 12. 
The best UV filter candidates provided with antioxidant activities are compound 3, 8 and 
12, that are still under study to verify the safety profile. Taking into account all results, i.e., 
in addiction to filtering and antioxidant capabilities, also cytotoxicity, 
phototoxicity,stability and photostabilty, the molecule that satisfy all requirement is 
compound 12. 
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12. Materials and Methods 
 
 
12.1 General 
Reactants, solvents and standard samples were purchased from Sigma-Aldrich, Milan, 
Italy. Reaction course was routinely monitored by thin-layer chromatography on pre-
coated silica gel plates (Macherey-Nagel Durasil-25) by detection under a 254-nm UV 
lamp and/or by spraying the plates with 1% FeCl3 solution in water and using as eluent 
dichloromethane/methanol (90:10) or butanol/ water/ acetic acid (60:20:20).    
The molecular weights of the compounds were determined by ESI (Micromass ZMD 
2000), and the values are expressed as [MH]+.  
1H-NMR spectra were determined in d6-DMSO and recorded on VXR-200 Varian 
spectrometer and Mercury Plus-400. Chemical shifts are expressed in parts per million (δ) 
relative to the TMS internal standard. 
UV spectrophotometric analyses were carried out on a UV-VIS spectrophotometer 
(ThermoSpectronic Helios γ, Cambridge, UK). 
 
 
12.2 Antioxidant Analyses 
Photochemiluminescence (PCL) assay was performer by means of Photochem® 
apparatus using PCL Kits purchased by Analytik-Jena AG (Jena, Germany). Production of 
superoxide anion radicals is sensitized from luminol after exposure to UV light lamp 
(Double Bore® phosphorus lamp, output 351 nm, 3 mWatt/cm2). The antioxidant activity 
was measured using ACL method (Antioxidant Capacity of Liposoluble). 
 A 2.30 mL portion of reagent 1 (HPLC-grade methanol), 0.2 mL of reagent 2 (buffer 
solution), 25 µL of reagent 3 (photosensitizer), and from 5 µL to 25 µL of standard trolox 
solution 0.1mM (to obtain the calibration curve) or sample solution proper diluted were 
mixed and measured, during a time of 130 seconds, by means of Photochem®. The 
antioxidant capacity of the sample is calculated by comparison with a Trolox standard 
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curve. The areas under the reaction curves were calculated using the PCLsoft control and 
analysis software; at greater concentrations of Trolox working solutions correspond a 
marked reduction in the magnitude of the PCL signal and hence a reduction of the area 
under the curve. This inhibition was used as a parameter for quantification of antioxidant 
capacity. 
 
DPPH (1,1-diphenyl-2-picrylhydrazyl) test. To 1.5 mL DPPH methanolic solution 0.5 
mM was added 0.750 mL of sample solution proper diluted.  Samples absorbance 
measurements were evaluated with a UV-VIS spectrophotometer (ThermoSpectronic 
Helios γ, Cambridge, UK) at fixed wavelength of 517 nm. Blank sample was prepared 
adding methanol to DPPH solution and Trolox was used as standard reference to achieve a 
calibration curve. The radical-scavenging activity is expressed as inhibition ratio of initial 
concentration of DPPH radical and is calculated according to the formula: Inhibition 
percentage (Ip) = [(AB-As)/AB] · 100; where AB and As are, respectively, the absorbance 
values of blank reaction and of the tested sample. 
 
FRAP method (Ferric Reducing/Antioxidant Power). The reagent for analysis was 
freshly prepared by mixing the following solutions in the reported ratio 10/1/1 (v:v:v) i) 
0.1 M acetate buffer pH 3.6, ii) TPTZ 10 mmol/L in 40 mmol/ HCl, iii) ferric chloride 20 
mmol/L. To a 1.9 mL of reagent were added 0.1 mL of sample proper diluted or solvent 
when blank was performed. Readings at fixed wavelength of the absorption maximum 
(593 nm) were done after 30 min, using a UV-VIS spectrophotometer; it was evaluated the 
absorbance increase of sample solution against the absorbance of blank reaction as 
parameter to calculate the antioxidant activity. The antioxidant activity is given as Trolox 
activity since this standard was used to perform the calibration curves.  
 
 
12.3 Evaluation of filtering parameters 
Sun protection factor evaluation was performed by means of UV-VIS spectrophotometer 
(ThermoSpectronic Helios γ, Cambridge, UK) and analytic program Spectra Analysis 
(Jasco Europe). Test formulation was applied in amount of 2mg/cm2 on Transpore tape, a 
support transparent to ultraviolet radiations and able to simulate the porosity and texture of 
human skin, and then the measure of UV transmittance was carried out. The cosmetic 
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product does not need any preliminary treatment; the sample is applied on the support 
surface and a glove finger it was used to spread the product and obtain a uniform layer. 
Before proceeding with the analysis it was recorded the baseline of the support and the 
UV-VIS spectrophotometer was checked measuring the SPF factor of COLIPA (Cosmetic 
Europe) standard cosmetic formulation that has to give SPF value between 15 and 18. In 
table 12.1 is shown composition of COLIPA (Cosmetic Europe) standard cosmetic 
formulation. 
Table 12.1 COLIPA standard formulation 
INCI % 
Phase I 57,6500 
Aqua 53,5700 
Phenylbenzimidazole sulfonic acid 2,7800 
Aqua, Sodium hydroxide 0,9000 
Methylparaben 0,3000 
Disodium EDTA 0,1000 
Phase II 21,7500 
Cetearyl alcohol, PEG-40 castor oil, Sodium cetearyl sulfate 3,1500 
Decyl oleate 15,0000 
Ethylhexyl methoxycinnamate 3,0000 
Butyl methoxydibenzoylmethane 0,5000 
Propylparaben 0,1000 
Phase III 20,6000 
Aqua 20,0000 
Carbomer 0,3000 
Aqua, Sodium hydroxide 0,3000 
Total 100,0000 
 
 
 
12.4 Cytotoxicity and Phototoxicity tests 
Cytotoxicity and phototoxicity tests are performed in Padova University by research team 
of Professor Vedaldi Daniela. 
Cellular culture. An immortalized, non-tumorigenic cell line of human keratinocytes 
(NCTC-2544) was grown in a DMEM medium (Sigma-Aldrich Milan, Italy), 
supplemented with 115 units/mL of penicillin G, 115 µg/mL streptomycin, and 10% fetal 
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calf serum (Invitrogen, Milan, Italy). Individual wells of a 96-well tissue culture microtiter 
plates (Falcon, Becton–Dickinson) were inoculated with 100 µL of complete medium 
containing 5 x 103 NCTC-2544. The plates were incubated at 37°C in a humidified (5% 
CO2) incubator for 18 h prior to the experiments. 
Cytotoxicity. After medium removal, 100 µL of the drug solution, dissolved in DMSO and 
diluted in DMEM medium, was added to each well, incubated at 37°C for 72 h. Final 
DMSO concentration never exceeded 0.5 %. Cell viability was assayed by the MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide) test as previously described 
by Mosmann.103 
Irradiation procedure. Two HPW 125 Philips lamps, mainly emitting at 365 nm, were 
used for UVA irradiation experiments. The spectral irradiance of the source was 4.0 mW 
cm-2 as measured at the sample level by a Cole-Parmer Instrument Company radiometer 
(Niles, IL, USA) equipped with a 365-CX sensor. One or two PL-S 9 W⁄ 12 Philips lamps 
(280–370 nm; peak at 315 nm) were used for UVB irradiation experiments. To restrict the 
incident radiation to the range 305– 370 nm, a glass filter (Schott SWG-305) was used. 
Total energy was detected by the same equipped with a sensor (model CX-312). 
Cellular photoprotection experiments. After medium removal, 100 µL of the drug 
solution, dissolved in DMSO and diluted with Hank’s Balanced Salt Solution (HBSS pH = 
7.2), was added to each well, incubated at 37°C for 30 min, and then irradiated (20 J/cm2 
for UVA and 0.5 and 1 J/cm2 for UVB). After irradiation, the solution was replaced with 
the medium and the plates were further incubated for 48 h. Cell viability was assayed by 
the MTT [(3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide)] test as 
previously described by Mosmann. 
 
 
12.5 HPLC analysis 
HPLC analysis was performed using an Agilent 1100 Series HPLC System equipped with 
a G1315A DAD, autosampler and with a Phenomenex Synergi Hydro-RP C-18 80Å 
column (4.6 ×  150 mm, 4 µm) fitted with a safety guard cartridge (Phenomenex). The 
column thermostat was manteined at 25°C during all the time of the analysis. Mobile phase 
consists of solvent A, H3PO4  0,01 M in water, and solvent B, H3PO4  0,01 M in 
acetonitrile. For molecule 3 and PBSA the mobile phase was composed by 91% of solvent 
A and 9% of solvent B at a flow rate of 1mL/min; determination was carried out in 
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isocratic condition, in 10 minute. Flow rate and run time remain the same for the analysis 
of molecule 8 and 10 but changes the solvent ratio, in analysis of these compounds the 
mobile phase was composed by 84% of solvent A and 16% of solvent B. Stability and 
photostability determinations were monitored with absorbance detection corresponding to 
λmax of the molecule ± 8 nm. The sample solutions were filtered by a 0.45 µm filter, before 
be injected into column (HPLC filters were purchased from Chemtek Analitica, Bologna, 
Italy). 
 
 
12.6 Photostability studies 
Photostability studies were carried out with a solar simulator device (Suntest CPS+; Atlas, 
Linsengericht, Germany) equipped with a Xenon lamp, an optical filter to cut off 
wavelengths shorter than 290 nm and an IR-block filter to avoid thermal effects. The solar 
simulator emission was maintained at 500 W/m2. A portion of cosmetic formulation 
containing the sunscreen molecule (3%, w/w) was transferred onto the bottom of a beacker 
to gain a cosmetic mount of 2mg/cm2 and then was irradiated for 1h with the solar 
simulator. After irradiation the beaker was removed and its content quantitatively 
transferred into a 50 mL calibrated flask with methanol and the remaining sunscreen 
concentration was determined by HPLC.  
All samples were protected from light both before and after irradiation, the degree of 
photodegradation was evaluated by comparing the areas of the irradiated samples, with 
those of the unirradiated preparations. 
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12.7 Synthetic procedures 
3,4-Diamino-benzenesulfonic acid, sulfate salt (1) 
o-Phenylenediamine (1 g, 9.25 mmol) was added to sulfuric acid 96% (5 mL) at 0°C under 
stirring for 1 hour, then the solution was heated to 137°C for 24 hours. The reaction 
mixture was cooled and was added 2-3 mL of cold water to get a white precipitate, which 
was filtered off, washed with methanol and filtered again to afford 1,77 g of white powder, 
yield 67%. 
 
1H NMR (DMSO): δ (ppm) 6,85 (d, 1H, Ar, Jorto= 8.4 Hz); 7,19 (dd, 1H, Ar, Jorto= 8.2Hz, 
Jmeta=1.8Hz); 7.37 ( 1H, Ar, Jmeta= 2Hz). 
ESI+ MS: m/z 188.3 Da [M + H]+, C6H10N2O7S2  Mol. Wt.: 286,28 
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2-(4-Hydroxy-phenyl)-1H-benzimidazole-5-sulfonic acid (2) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 1 (100 
mg, 0.35 mmol) in ethanol (5 mL) was added a solution of sodium bisulfite 1N in water  
(0.7 mL, 0.7 mmol) and 4-Hydroxy-benzaldehyde (46 mg, 0.35 mmol); the reaction 
mixture was heated at 80°C under reflux for 24 hours. The solvent was then evaporated 
under reduced pressure, the solid was washed with HCl 1N to precipitate the interest 
product, the suspension was filtered and the solid washed with methanol to afford 60 mg of  
desired product. Light yellow powder, yield 60%. 
 
1H NMR (DMSO): δ (ppm) 7.09 (d, 2H, aryl, J= 9.2 Hz); 7.73 (d, 1H, benzimidazole, J= 
8.4 Hz); 7.78 (d, 1H, benzimidazole, J= 8.4 Hz); 7.91 (s, 1H, benzimidazole); 8.06 (d, 2H, 
aryl, J= 8.8 Hz); 10,78 (s, broad, 1H, -OH); 13.4-15.8 (s, broad, 2H, -SO3H, -NH). 
ESI+ MS: m/z 290.5 Da [M + H]+; C13H10N2O4S; Mol. Wt.: 290.30 
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2-(3,4-Dihydroxy-phenyl)-1H-benzimidazole-5-sulfonic acid (3) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 1 (100 
mg, 0.35 mmol) in ethanol (5 mL) was added a solution of sodium bisulfite 1N in water 
(0.7 mL, 0.7 mmol) and 3,4-Dihydroxy-benzaldehyde (48 mg, 0.35 mmol);  the reaction 
mixture was heated at 80°C under reflux for 24 hours. The solvent was then evaporated 
under reduced pressure, the solid was washed with HCl 1N to precipitate the interest 
product, the suspension was filtered and the solid washed with methanol to afford 60 mg of  
desired product. White powder, yield 56%. 
 
1H NMR (DMSO): δ (ppm) 7.05 (d, 1H, aryl, J= 8 Hz); 7.52-7.56 (m, 2H, aryl); 7.68 (d, 
1H, benzimidazole, J= 8.4 Hz); 7.75 (dd, 1H, benzimidazole, Jorto= 8.4 Hz, Jmeta= 1.6 Hz);  
7.88 (s, 1H, benzimidazole); 9.75 (s, broad, 1H, -OH); 10.4 (s, broad, 1H, -OH); 13.8-15.6 
(s, broad, 2H, -SO3H, -NH). 
ESI+ MS: m/z 306,7 Da [M + H]+; C13H10N2O5S; Mol. Wt.: 306.29 
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2-(2-Hydroxy-phenyl)-1H-benzimidazole-5-sulfonic acid (4) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 1 (100 
mg, 0.35 mmol) in ethanol (5 mL) was added a solution of sodium bisulfite 1N in water 
(0.7 mL, 0.7 mmol) and 2-Hydroxy-benzaldehyde (40 µL, 0.35 mmol); the reaction 
mixture was heated at 80°C under reflux for 24 hours. The solvent was then evaporated 
under reduced pressure, the solid was washed with HCl 1N to precipitate the interest 
product, the suspension was filtered and the solid washed with methanol to afford 94 mg of  
desired product. White powder, yield 70%. 
 
1H NMR (DMSO): δ (ppm) 7.13-7.17 (m, 1H, phenyl); 7.20 (d, 1H, aryl, J= 7.6 Hz); 7.56-
7.60 (m, 1H, aryl); 7.75-7.80 (m, 2H); 8.04 (s, 1H, benzimidazole); 8.06 (dd, 1H, Jorto = 8 
Hz, Jmeta= 2.4 Hz); 11.9- 14.2 (s, braod, 3H, -OH, -SO3H, -NH). 
ESI+ MS: m/z 290.8 Da [M + H]+; C13H10N2O4S; Mol. Wt.: 290.30 
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2-(2,4-Dihydroxy-phenyl)-1H-benzimidazole-5-sulfonic acid (5) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 1 (100 
mg, 0.35 mmol) in ethanol (5 mL) was added a solution of sodium bisulfite 1N in water 
(0.7 mL, 0.7 mmol) and 2,4-Dihydroxy-benzaldehyde (48 mg, 0.35 mmol);  the reaction 
mixture was heated at 80°C under reflux for 24 hours. The solvent was then evaporated 
under reduced pressure, the solid was washed with HCl 1N to precipitate the interest 
product, the suspension was filtered and the solid washed with methanol to afford 65 mg of 
desired product. White powder, yield 56%. 
 
1H NMR (DMSO): δ (ppm): 6.57 (dd, 1H, aryl, Jorto = 8.8 Hz, Jmeta= 2.4 Hz); 6.611 (s, 1H, 
aryl); 7.69-7.75 (m, 2H, benzimidazole); 7.90 (d, 1H aryl, Jorto = 8.8 Hz); 7.99 (s, 1H, 
benzimidazole); 10.66 (s, broad, 1H, -OH); 11.74 (s, broad, 1H, -OH); 13.87 (s, broad, 2H, 
-SO3H, -NH). 
ESI+ MS: m/z 306.7 Da [M + H]+; C13H10N2O5S; Mol. Wt.: 306.29 
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2-(2,3,4-Trihydroxy-phenyl)-1H-benzimidazole-5-sulfonic acid (6) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 1 (100 
mg, 0.35 mmol) in ethanol (5 mL) was added a solution of sodium bisulfite 1N in water 
(0.7 mL, 0.7 mmol) and 2,3,4-Trihydroxy-benzaldehyde (54 mg, 0.35 mmol);  the reaction 
mixture was heated at 80°C under reflux for 24 hours. The solvent was then evaporated 
under reduced pressure, the solid was washed with HCl 1N to precipitate the interest 
product, the suspension was filtered and the solid washed with methanol to afford 82 mg of  
desired product. Whitish powder, yield 73%. 
 
1H NMR (DMSO): δ (ppm) 6.64 (d, 1H, aryl, Jorto = 8,8 Hz); 7.42 (d, 1H, aryl, Jorto = 8,8 
Hz); 7.70-7.78 (m, 2H, benzimidazole);  7.99 (s, 1H, benzimidazole); 9.2 (s, broad, 1H, -
OH); 10.45 (s, broad, 1H, -OH); 13.8-14.0 (s, broad, 3H, -SO3H, -NH,-OH). 
ESI+ MS: m/z 322.4 Da [M + H]+; C13H10N2O6S; Mol. Wt.: 322.29 
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2-(4-Hydroxy-phenyl)-1H-benzimidazole (7) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of    o-
Phenylenediamine (100 mg, 0.92 mmol) in ethanol (5 mL) was added a solution of sodium 
bisulfite 1N in water (1.84 mL, 1.84 mmol) and 4-Hydroxy-benzaldehyde (112 mg, 0.92 
mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. The solvent was 
then evaporated under reduced pressure, the solid was washed with HCl 1N to precipitate 
the interest product, the suspension was filtered and the solid washed with methanol to 
afford 150 mg of  desired product. Light yellow powder, yield 77%. 
 
1H NMR (DMSO): δ (ppm): 7.03 (d, 2H, aryl, Jorto= 8.8); 7.38-7.41 (m, 2H, 
benzimidazole); 7.69-7.7 (m, 2H, benzimidazole); 8.14 (d, 2H, aryl, J= 8.8 Hz); 10.55 (s, 
broad, 1H, -OH); 14.63 (s, broad, 1H, -NH).  
ESI+ MS: m/z Da 211.5[M + H]+; C13H10N2O; Mol. Wt.: 210.23 
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2-(3,4-Dihydroxy-phenyl)-1H-benzimidazole (8) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of    o-
Phenylenediamine (100 mg, 0.92 mmol) in ethanol (5 mL) was added a solution of sodium 
bisulfite 1N in water (1.84 mL, 1.84 mmol) and 3,4-Dihydroxy-benzaldehyde (127 mg, 
0.92 mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. The solvent 
was then evaporated under reduced pressure, the solid was washed with HCl 1N to 
precipitate the interest product, the suspension was filtered and the solid washed with 
methanol to afford 132 mg of  desired product. Light brown powder, yield 64%. 
 
 
1H NMR (DMSO): δ (ppm): 7.06 (d, 1H, J= 8 Hz); 7.49-7.51 (m, 2H); 7.67-7.70 (m, 2H); 
7.75-7.77 (m, 2H); 9.7 (s, broad, 1H, -OH); 10.4 (s, broad, 1H, -OH); 15 (s, broad, 1H, -
NH). 
ESI+ MS: m/z 226.5 Da [M + H]+; C13H10N2O2; Mol. Wt.: 226.23 
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2-(2,4-Dihydroxy-phenyl)-1H-benzimidazole (9) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of    o-
Phenylenediamine (100 mg, 0.92 mmol) in ethanol (5 mL) was added a solution of sodium 
bisulfite 1N in water (1.84 mL, 1.84 mmol) and 2,4-Dihydroxy-benzaldehyde (127 mg, 
0.92 mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. The solvent 
was then evaporated under reduced pressure, the solid was washed with HCl 1N to 
precipitate the interest product, the suspension was filtered and the solid washed with 
methanol to afford100 mg of  desired product. Light brown powder, yield 48%. 
 
1H NMR (DMSO): δ (ppm): 6.57 (dd, 1H, aryl, Jorto= 8.8 Hz, Jmeta= 2.4 Hz); 6.74 (d, 1H, 
aryl, Jmeta= 2 Hz ); 7.48-7.50 (m, 2H, benzimidazole); 7.79-7.81 (m, 2H, benzimidazole); 
8.05 (d, 1H, aryl, Jorto=8.8 Hz); 10.76 (s, broad, 1H, -OH); 11.90 (s, broad, 1H, -OH); 
14.13 (s, braod, 1H, -NH). 
ESI+ MS: m/z 226.6 Da [M + H]+; C13H10N2O2; Mol. Wt.: 226.23 
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2-(2-Hydroxy-phenyl)-1H-benzimidazole (10) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of    o-
Phenylenediamine (100 mg, 0.92 mmol) in ethanol (5 mL) was added a solution of sodium 
bisulfite 1N in water (1.84 mL, 1.84 mmol) and 2-Hydroxy-benzaldehyde (96 µL, 0.92 
mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. The solvent was 
then evaporated under reduced pressure, the solid was washed with HCl 1N to precipitate 
the interest product, the suspension was filtered and the solid washed with methanol to 
afford 173 mg of  desired product. White powder, yield 89%. 
 
1H NMR (DMSO): δ (ppm): 7.0-7.05 (m, 2H); 7.25-7.32 (m, 2H); 7.36-7.41 (m, 1H); 7.61 
(d, 1H, J= 7.6); 7.72 (d, 1H, J= 7.6 Hz); 8.06 (dd, 1H, Jorto= 7.6 Hz, Jmeta= 1.6 Hz); 13.16 
(s, 1H, -OH); 13.21 (s, broad, 1H, -NH). 
ESI+ MS: m/z Da 211.5[M + H]+; C13H10N2O; Mol. Wt.: 210.23 
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2-(2,3,4-Trihydroxy-phenyl)-1H-benzimidazole (11) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of    o-
Phenylenediamine (100 mg, 0.92 mmol) in ethanol (5 mL) was added a solution of sodium 
bisulfite 1N in water (1.84 mL, 1.84 mmol) and 2,3,4-Trihydroxy-benzaldehyde (142 mg, 
0.92 mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. The solvent 
was then evaporated under reduced pressure, the solid was washed with HCl 1N to 
precipitate the interest product, the suspension was filtered and the solid washed with 
methanol to afford 208 mg of  desired product. Light brown powder, yield 93%. 
 
1H NMR (DMSO): δ (ppm): 6.66 (d, 1H, aryl, Jorto= 8.8 Hz); 7.45-7.50 (m, 2H, 
benzimidazole); 7.59 (d, 1H, aryl, Jorto = 8.8 Hz); 7.77-7.782 (m, 2H, benzimidazole); 9.2 
(s, broad, 1H, -OH); 10.4 (s, broad, 1H, -OH fenolico); 14 (s, broad, 2H, -NH,-OH). 
ESI+ MS: m/z 242.6 Da [M + H]+; C13H10N2O3; Mol. Wt.: 242.23 
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2-(3,4-Dihydroxy-phenyl)-1H-benzimidazole-5-carboxylic acid (12) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 3,4-
Diaminobenzoic acid (100 mg, 0.66 mmol) in ethanol (5 mL) was added a solution of 
sodium bisulfite 1N in water (1.32 mL, 1.32 mmol) and 3,4-Dihydroxy-benzaldehyde (91 
mg, 0.66 mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. The 
solvent was then evaporated under reduced pressure, the solid was washed with HCl 1N to 
precipitate the interest product, the suspension was filtered and the solid washed with 
methanol to afford 135 mg of  desired product. Light brown powder, yield 76%. 
 
1H NMR (DMSO): δ (ppm): 7.06 (d, 1H, J= 8 Hz); 7.69-7.73 (m, 2H); 7.82 (d, 1H, J= 8.4 
Hz); 8.05 (dd, 1H, Jorto= 8.4 Hz, Jmeta= 1.6 Hz); 8.25 (s, 1H); 9.8 (s, broad, 1H, -OH 
fenolico ); 10.5 (s, broad, 1H, -OH). 
ESI+ MS: m/z 270.7 Da [M + H]+; C14H10N2O4; Mol. Wt.: 270.24 
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2-(2,4-Dihydroxy-phenyl)-1H-benzimidazole-5-carboxylic acid (13) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 3,4-
Diaminobenzoic acid (100 mg, 0.66 mmol) in ethanol (5 mL) was added a solution of 
sodium bisulfite 1N in water (1.32 ml, 1.32 mmol) and 2,4-Dihydroxy-benzaldehyde (91 
mg, 0.66 mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. The 
solvent was then evaporated under reduced pressure, the solid was washed with HCl 1N to 
precipitate the interest product, the suspension was filtered and the solid washed with 
methanol to afford 140 mg of  desired product. Light brown powder, yield 78%. 
 
1H NMR (DMSO): δ (ppm): 6.57 (dd, 1H, Jorto = 8.8 Hz, Jmeta = 2.0 Hz); 6.67 (s, 1H); 7.83 
(d, 1H, J= 8.8 Hz);  8.03 (dd, 2H, Jorto= 8.8, Jmeta= 1.2 Hz); 8.31 (s, 1H);  10.7 (s, broad, -
OH) 12.4-14.6 ( s, broad, 3H, -OH, -NH, -COOH ). 
ESI+ MS: m/z 270.7 Da [M + H]+; C14H10N2O4; Mol. Wt.: 270.24 
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2-(4-Hydroxy-phenyl)-1H-benzimidazole-5-carboxylic acid (14) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 3,4-
Diaminobenzoic acid (100 mg, 0.66 mmol) in ethanol (5 mL) was added a solution of 
sodium bisulfite 1N in water (1.32 mL, 1.32 mmol) and 4-Hydroxy-benzaldehyde (80.6 
mg, 0.66 mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. The 
solvent was then evaporated under reduced pressure, the solid was washed with HCl 1N to 
precipitate the interest product, the suspension was filtered and the solid washed with 
methanol to afford 146 mg of  desired product. Light brown powder, yield 87%. 
 
1H NMR (DMSO): δ (ppm): 7.09 (d, 2H,  Jorto= 8.8 Hz); 7.84 (d, 1H, Jorto= 8.4 Hz); 8.06 
(d, 1H, Jorto= 8.4 Hz); 8.22 (m, 2H); 8.26 (s, 1H); 10.85 (s, broad, 1H, -OH); 14-16 (s, 
broad, 2H, -COOH, -NH). 
ESI+ MS: m/z 254.7 Da [M + H]+; C14H10N2O3; Mol. Wt.: 254.24 
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2-(2,3,4-Trihydroxy-phenyl)-1H-benzimidazole-5-carboxylic acid (15) 
In a round-bottomed flask (50 mL) equipped with a magnetic stirrer, to a solution of 3,4-
Diaminobenzoic acid (100 mg, 0.66 mmol) in ethanol (5 mL) was added a solution of 
sodium bisulfite 1N in water (1.32 mL, 1.32 mmol) and 2,3,4-Trihydroxy-benzaldehyde 
(102 mg, 0.66 mmol); the reaction mixture was heated at 80°C under reflux for 24 hours. 
The solvent was then evaporated under reduced pressure, the solid was washed with HCl 
1N to precipitate the interest product, the suspension was filtered and the solid washed 
with methanol to afford 151 mg of  desired product. Light pink  powder, yield 80%. 
 
1H NMR (DMSO): δ (ppm): 6.65 (d, 2H, Jorto= 8.8 Hz); 7.58 (d, 1H, Jorto= 8.8 Hz); 7.82 (d, 
1H, Jorto= 8.6 Hz, ); 8.02 (dd, 1H, Jorto= 8.6 Hz, Jmeta= 1.6 Hz ); 8.26 (d, 1H, Jmeta= 1.6 Hz ); 
10.2-11 (s, broad, 2H, -OH); 13-14 (s, broad, 3H, -OH  -COOH, -NH). 
ESI+ MS: m/z 286.4 Da [M + H]+; C14H10N2O5; Mol. Wt.: 286.24 
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